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ABSTRACT 
 
The development of fully-implantable therapeutic and diagnostic devices 
represents a new paradigm in biomedical device design.  However, designing materials 
that can perform as injectable matrices for the delivery of sensing and therapeutics 
chemistries while retaining control over sensor and drug release behaviors is a complex 
problem.  The novel material described herein, microporous alginate composite 
(MPAC), allows for controllable in situ gelation—and hence enables injection—as well 
as encapsulation of functional elements such as sensing chemistries or therapeutics.  As 
this material has never been described before, individual component materials, bulk 
mechanical and gelation properties, and sensing composite response characteristics were 
examined.   
The use of polyelectrolyte multilayers (PEMs) in fabrication of MPACs resulted 
in a porous composite in which macromolecules and nanoparticles were retained within 
the pores, while allowing for free movement of these materials.  Entrapped enzyme 
molecules were shown to react with diffusing substrates from outside the matrix, 
confirming the ability of materials from within the pores to interact with small molecules 
in the local environment. 
Increasing numbers of PEMs used in composite fabrication was found to result in 
increased gelation times of hydrogels, while increasing particle concentration reduced 
gelation times.  Changes in pH during MPAC gelation was also dependent on 
microsphere concentration and PEM numbers.  After gelation, MPAC hydrogels 
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immersed in water displayed complex swelling and stiffening behavior dependent on 
particle concentration and PEM numbers. 
Oxygen-sensing MPAC hydrogels displayed minor PEM-dependent behavior, 
while glucose-sensing MPAC hydrogels displayed strong dependence on concentration 
and PEM numbers.  As concentrations increased, sensitivities increased and analytical 
ranges decreased indicating cooperative behavior among enzyme-containing pores. 
Utilizing low permeability nanofilms, sensitivities and ranges of sensors could be 
modulated based upon the number of layers used in fabrication. 
The development of this new composite system architecture permits an added 
level of control over injectable hydrogel physical and functional properties such as 
gelation time and sensor response characteristics.  This added control could broaden the 
usage of alginate as an injectable material and lead to the development of a wide variety 
of new functional injectable devices. 
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1. INTRODUCTION 
 
Chronic disease can be defined as a persistent state of disease that continues 
despite (or as a cause of) the body’s attempts to regulate itself.  In many cases, these 
conditions can be controlled, but are usually not curable.  Due in part to the advances of 
medical science in the treatment of conditions resulting from infectious diseases, 
increased life expectancies, and the epidemic levels of obesity and sedentary lifestyles, 
chronic disease has become the major contributor to health concerns among the world’s 
population.1  In the United States alone, chronic diseases represent over 75% of 
healthcare costs and are the leading cause of death and disability.2 
Treatment of these conditions has been notoriously difficult, as the underlying 
mechanisms of the diseases are extraordinarily complex and not yet fully understood.  
As of yet, pharmaceutical techniques, which classically have involved the administration 
of small-molecule therapeutics in pill form, have been insufficient to control these 
diseases or completely reduce the associated risks.  As such, there has been a large drive 
to develop new approaches utilizing biomedical technology in place of, or in 
combination with, pharmaceutical therapeutics.  The advent of certain technologies, 
namely nanotechnology and specially-designed biocompatible biomaterials, has 
accelerated the development of treatments by providing a wide range of new mechanistic 
tools for scientists and doctors to utilize.3-6  Biomedical approaches utilizing these tools 
aim to improve the lives of people suffering from chronic disease by either directly 
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curing the diseases themselves or controlling the disease state to minimize or eliminate 
the negative effects of the disease on the person and their body. 
While there are many biomedical strategies for combating chronic disease, 
certain approaches have the potential to improving outcomes.  Two such examples 
include the continuous monitoring of bioanalytes for predictive/adaptive treatment and 
the controlled local delivery of therapeutics.  Although these two management/treatment 
strategies can be implemented separately, the two approaches could, in principle, be 
coupled together in a fully-implantable device to improve outcomes beyond what could 
be achieved with an individual approach alone.  In either case, sensing chemistry and/or 
therapeutics must be delivered to the site of interest in a minimally-invasive, controllable 
manner where they can reside for an extended period of time to perform their function.   
Fully implantable materials administered via injection offer a means to accomplish this. 
Injectable systems must be tailored to their specific applications, and control over 
mechanical and functional properties of the system is crucial to their success.  For 
continuous sensing applications, sensing molecules within an injectable system must be 
able to be encapsulated within it, retained during the lifetime of the sensor, and allowed 
to access the surrounding body fluid or tissue in a manner which allows for precise, 
accurate measure of the analyte of interest within the range of values expected in vivo.  
For therapeutic delivery, the system must be able to encapsulate and release therapeutic 
elements in an effective manner (controlled release).  Control over these functional 
properties can be accomplished by altering bulk material properties in systems 
comprising a single function.  However, when multiple functional elements are 
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combined into a single system, changing bulk material properties can affect the function 
of all elements contained within.  Therefore, in designing multifunctional systems for 
sensing and/or therapeutics delivery, it is desirable to have additional tools/mechanisms 
for independent modulation of the system’s functional characteristics. 
To address the need for a tunable injectable system with sensor and therapeutics 
delivery capability, a novel composite system combining the tunable properties of 
polyelectrolyte nanofilms with the biocompatible nature of hydrogels was proposed.  
This dissertation work describes the preliminary development and characterization of 
this platform technology: one that can be utilized for the monitoring of analytes and 
delivery of therapeutics at sites of interest with easily tunable properties that could be 
tailored for a variety of applications.  This material results from the mixing of the 
biomaterial alginate along with nanofilm-coated CaCO3 particles and the acidifier 
glucono-δ-lactone.  The combination of these materials forms in a hydrogel composite 
with nanofilm-coated microdomains, where encapsulated material is selectively retained 
or released.  As this composite material has never before been evaluated, independent 
but related studies investigating the physical and functional attributes of the material 
were performed for the purpose of providing a basis for its further use in multimodal 
and/or multifunctional applications. 
The content of this dissertation has been organized in a way to best explain the 
development and characterization of the material from inception to functional evaluation 
with a focus on the effects of tunable fabrication parameters.  After a brief overview of 
relevant background information in Section 2, subsequent Sections (3-5) represent 
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separate publication material with focus on respective aspects or functions of the 
composite material.  Section 3 describes the initial functional evaluation of the 
composite, with a focus on the fundamental system design requirements including 
encapsulation of materials, morphological characterization, and basic interactions with 
external analytes.  Portions of the work in this section were published in Journal of 
Materials Chemistry B.7  Section 4 describes the physical and mechanical 
characterization of the composite material, including gelation kinetics, mechanical 
properties and mechanical stability as a function of nanofilm architecture and particle 
concentration (porosity).  Section 5 describes the characterization of sensor composites 
including oxygen and glucose-sensing constructs.  This section describes the tuning of 
sensor response characteristics utilizing composite fabrication parameters of porosity 
and nanofilm architecture.  Finally, Section 6 describes the future direction of the work, 
including progression of the material into a multifunctional and/or multimodal sensing 
platform, as well as its initial in vivo evaluation.  Preliminary work with additional 
functional composites including model therapeutic delivery and RAMAN-sensitive 
chemistry are discussed. 
  
 5 
2. BACKGROUND* 
 
In the field of biomedical engineering, the use of hydrogels is ubiquitous.  
Hydrogels, which are three-dimensional, hydrophilic, polymeric networks capable of 
imbibing large amounts of water or biological fluids, have had a long and impactful 
history in biomedical engineering since their first appearance.8-10  In recent years, 
interest has shifted to in situ-gelling hydrogels for biomedical implants over other 
implantable hydrogels due to the numerous advantages such systems can offer, such as 
minimized invasiveness and cost (Figure 1).9, 11-14 
2.1 Injectable hydrogel materials 
 
 
Figure 1: An in situ-forming hydrogel material injected under the skin. 
 
                                                 
*Parts of this section have been reprinted from J. R. Roberts, D. W. Ritter and M. J. McShane, Journal of 
Materials Chemistry B, 2013, 1, 3195-3201 – Reproduced by permission of The Royal Society of 
Chemistry. 
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Injectable hydrogel materials, and more specifically in situ-gelling materials, are 
injected in liquid form to the site of interest, allowing the material to form to the 
environment.  After placement, a stimulus is provided to cause the material to transition 
into a gel state. There have been many approaches to in situ-gelling systems, involving a 
variety of different materials and gelation stimuli. 
2.1.1 Covalently crosslinked materials 
Many hydrogel systems comprise synthetic polymers such as poly(hydroxyethyl 
methacrylate), poly(ethylene glycol), poly(vinyl alcohol) or other methacrylate-
containing monomers and crosslinkers.15-17  Classically, these systems have utilized 
chemical reactions such as free radical polymerization or other chemical mechanisms to 
control crosslinking/stiffening of the hydrogel material.  While these systems’ gelling 
kinetics are proven reliable and robust, they can have drawbacks as injectable systems 
because they can have toxic/immunogenic monomers and degradation products, free 
radical production, or the need for UV radiation.18  As a result, many groups have 
worked on creating in situ-forming hydrogels from synthetic polymer or 
synthetic/natural blend materials that do not require excessive heat, damaging UV 
radiation and that do not produce toxic byproducts.  There have been several approaches 
to creating such materials under mild conditions, including Michael-type Addition,19-26 
disulfide bond formation,27-29 Schiff base formation,29-32 and more recently, Click 
chemistry33-35 and enzymatic-mediated crosslinking.36  These methods benefit from the 
much stronger covalent bonding formed during crosslinking, which can increase the 
strength of the hydrogels and increase the retention time of the polymer in the site of 
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interest.  Additionally, though the gels must be limited to certain functional groups for 
chemistries to function, there are nearly infinite numbers of monomer/polymer 
combinations that could produce a wide variety of materials.  However, making small 
changes in monomer/polymer structure or monomer ratios can have dramatic impact on 
the gel physical structure that can be difficult to predict and optimize.  This has led to the 
excruciatingly slow iteration of formulation testing with polymeric biomaterial systems.   
2.1.2 Physically crosslinked materials 
Parallel to research in covalent crosslinked systems, investigators have looked to 
systems utilizing physical crosslinking mechanisms, in which hydrogels are held 
together by non-covalent interactions and no chemical reactions take place during 
gelation.  These interactions can include, but are not limited to, electrostatic, ionic, 
stereocomplexation, hydrophobic, or other chemical interactions that can be modulated 
by temperature, pH, or ionic strength.9, 18  Physically-gelled hydrogels have some 
significant advantages over covalently-crosslinked hydrogels including biocompatibility 
and mild formation conditions.18  However, the materials that can be utilized are 
significantly more limited due to their chemical complexity.  These systems, such as 
peptide gels, extracellular matrix analogs, and special synthetics, can be induced to gel 
by temperature,37-40 ionic/electrostatic interactions,41-43 or hydrophobic interactions.44, 45   
Of physically crosslinking hydrogels, investigators have a renewed interest in 
natural materials such as the polysaccharides alginate, pectin and chitosan due to their 
unique physical properties and biocompatibility as well as their low cost and sustainable 
production.46-48  These materials can be stimulated to gel with exposure to ionic species, 
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with calcium-gelled alginate in particular seeing widespread use.7, 49-78  However, the 
gelation rate of these materials has been notoriously difficult to control due to the rapid 
diffusion of ionic crosslinking species through their hydrophilic matrices.68, 79  For these 
materials to function as an in situ-gelling system, the gels must either be exposed to 
large amounts of crosslinking ions in the environment in which they are injected or the 
transport/production of ionic crosslinkers to/in the pregel must be slowed as to prevent 
gelation prior to implantation.  For alginate, this presents an obstacle as there are very 
low levels of calcium ions in body fluid and there is little in the way of control of ion 
transport within the alginate itself, short of lowering the concentration of ions, which 
limits the hydrogel’s overall mechanical strength.80   
As of yet, there have not been any mechanistic advances since the development 
of internal gelation that have allowed for ionically-crosslinked materials such as alginate 
to be used as a true in situ-gelling material.  The proposed composite material solves the 
current problems with injectable ionically-crosslinked materials by utilizing 
polyelectrolyte multilayers to slow the delivery of crosslinking ions to the matrix, 
allowing for the composite to stay in liquid form for longer, permitting injection of the 
material.  This advance could allow for the development of a variety of different 
functional materials based utilizing the advantageous properties of natural biomaterials. 
2.2 Alginate and other naturally-derived materials 
Alginate, pectin, chitosan, collagen, and gelatin represent just a few of the natural 
biomaterials being utilized in biomedical research.25, 29, 47, 53, 59, 70, 81-88  These materials 
have distinct advantages over synthetic materials in a variety of ways.  Primarily, these 
 9 
materials resemble extracellular matrix, and so generally have good biocompatibility.76  
In addition, the gelation of these materials can be done under extremely mild conditions, 
allowing for minimal adverse effects on surrounding tissue and allowing for the 
encapsulation of whole cells for tissue engineering or tissue transplantation.54, 83, 89, 90 
2.2.1 Naturally-derived materials 
Naturally-derived materials are simply materials produced by organisms or 
modified directly from such materials.  Some examples of these materials include 
alginate (harvested from various seaweed species), pectin (harvested from plant species), 
and gelatin (harvested from animal species).  Many of these substances serve as or 
resemble native extracellular matrix for the organisms that produce them, and so have 
comparable properties to human extracellular matrix materials, and generally have 
favorable biocompatibility when purified properly. 41, 70, 91, 92  
2.2.2 Alginate 
One well-studied bulk encapsulation material is the biomaterial alginate, a linear 
polysaccharide consisting of the negatively-charged sugars β-D-mannuronate and α-L-
guluronate (Figure 2).93, 94 
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Figure 2: Structure of alginate comprising mannuronate and guluronate residues in 
random fashion. 
 
Alginate is derived from several different seaweed species, and serves as 
extracellular matrix, protective coating, and energy storage for the algal cells.78, 95 
Depending on the organism, alginate can be a variety of molecular weights and 
compositions, though alginate varieties will only contain mannuronate and guluronate 
moieties.57, 96  These negatively charged moieties allow for alginate to form a hydrogel 
in the presence of divalent cations such as calcium, barium, strontium, etc.96, 97  
Guluronic acid blocks are generally accepted as the groups primarily responsible for the 
divalent ion crosslinking of the macromolecular units and the hydrogel formation.96  
Guluronic acid groups form an “egg box” structure around divalent cations, physically 
linking two alginate chains together (Figure 3).98-100 
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Figure 3: Alginate physical crosslinking by calcium ions.  Guluronic acid blocks 
associate with calcium ions to form the “egg box” structure. 
 
Higher quantities of guluronic acid groups within an alginate result in stronger 
hydrogels when exposed to divalent cations and have increased stiffness.71  Mannuronic 
acid moieties can associate with divalent cations, but the interaction is much weaker.  
Mannuronic acid moieties are more labile than guluronic acid moieties, and so serve as a 
plasticizing element within the hydrogel.71 
Alginate hydrogels have many attractive physicochemical properties, such as 
relatively high mechanical strength, high water content, and gel formation under mild 
conditions.50, 58, 71, 72, 101, 102  Additionally, the biocompatibility of purified alginate 
hydrogels has generally been shown to be very high, though there remains an ongoing 
investigation into the many factors affecting the material’s biocompatibility (e.g., 
purification process, mannuronic-guluronic acid ratio, etc).54, 66, 91, 92, 103, 104  Due to the 
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numerous advantageous properties of alginate, there has been great interest in the 
material for a wide variety of biomedical applications. 
2.2.3 Gelation mechanisms and strategies 
Alginate gelation simply requires the presence of divalent cations.  However, the 
delivery and diffusion of the divalent cations has a dramatic impact on the gelation 
kinetics and the resulting hydrogel physical structure.   Most alginate gels have 
historically been gelled by what is referred to as “external gelation” in which a solution 
containing a soluble divalent cation salt is put into contact with a sodium alginate-
containing solution (Figure 4, left).57, 76, 78, 105-108   
 
 
Figure 4: Mechanisms of alginate gelation.  Left: External gelation by addition of 
calcium ions externally. Right: Internal gelation utilizing CaCO3 and GDL in a 
well-mixed suspension. 
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In this case, diffusion of ions into the alginate matrix is the primary driver behind 
gel crosslinking.  The divalent cations cross the hydrogel-solvent boundary and interact 
with the exterior of the alginate first.  This interaction results in organization of the 
hydrogel-solvent boundary and a heavy local crosslink density.105  As the cations diffuse 
into the hydrogel, there are fewer G-blocks available for crosslinking due to their 
occupation at the boundary, and therefore lower crosslink densities.105  Overall, this 
process results in a non-homogenous gel, with stronger exterior regions and much softer 
inner regions and an overall lower smechanical strength.105  However, in systems such as 
micro and nanospheres, the hydrogel-solvent boundary represents nearly the entire 
volume of the hydrogel, and so this is an effective method for creating micro and 
nanogels.83, 107, 109, 110 
More recently, alginate has been gelled using a technique referred to as “internal 
gelation.”  In this method, insoluble divalent cation salts, such as CaCO3 and CaSO4 are 
mixed with alginate.68  As a result of their low solubility, the salts cannot crosslink the 
hydrogel alone.  A secondary reagent, glucono-δ-lactone (GDL) is added to the mixture 
to begin the gelation process (Figure 4, right).  The GDL is an acidifier, and hydrolyzes 
in water to become gluconic acid.  The acidification of the solution increases the 
solubility of the salts, and releases the ions into the environment.  Due to the salts being 
well mixed into the alginate matrix, the release of ions into the alginate happens through 
the hydrogel volume.  This results in a much stronger and more homogenous hydrogel 
overall.68  It is important to note that this method depends upon many processes 
including the hydrolysis of GDL, diffusion of GDL, dissolution of insoluble salts and 
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diffusion of ions after dissolution.  As such, control over these processes, such as 
temperature modulation, buffering effects, or diffusional changes could affect the 
gelation behavior. 
2.3 Layer-by-layer deposition 
Layer-by-layer (LbL) self-assembly has been used in a variety of applications to 
control diffusion of solutes and modify surface interfacial properties.111-116  LbL films 
can be deposited onto a substrate—ranging in size and geometry from large planar 
substrates to micro- or nanoparticles—via a repetitive process of adsorption of  
interacting species, such as oppositely-charged polyelectrolytes.117  The resulting 
multilayers can be manufactured in a controllable manner with respect to their physical 
and functional characteristics (e.g., thickness, permeability, and interfacial properties), 
making them useful in biomedical applications such as bionanoreactors,118 
nanofiltration,114, 115 drug delivery,119-121 and biosensors.122-125 
2.3.1 Electrostatic adsorption 
Electrostatic adsorption refers to a layer-by-layer deposition technique that 
involves the deposition of alternatively charged polymers onto a substrate.117  In this 
process, a substrate, which could be a variety of geometries, is exposed to a 
polyelectrolyte solution (Figure 5). 
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Figure 5: Layer-by-Layer adsorption of polyelectrolytes by electrostatic 
interactions. 
 
The polymer chains in the solution will adsorb to the surface via charge 
interactions and will continue to adsorb until the changing surface charge leads to 
repulsion of additional polymer.117  The substrate can then be washed and exposed to 
oppositely charged polymers, which adsorb to the coated substrate surface in a similar 
fashion.  This process can be repeated until the desired number of layers are deposited.  
The process is self-limiting, and so can be done in a predictable and repeatable fashion 
for many cycles.117  Control over polymer types, charge density, layer numbers and salt 
concentrations are a few of the parameters that can be modulated to control the 
thickness, permeability and interfacial properties of the films, allowing for a great 
variety of different film architectures and characteristics.112, 115, 116, 122, 123, 126-131  
Diffusion control of substances throught the nanofilms is of particular importance to a 
variety of applications.  The ability to tune the permeability of nanofilms has lead to 
widespread interest in their use in drug delivery devices and as sensor coatings.128, 132-134 
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2.3.2 Calcium carbonate-based capsules 
Calcium carbonate is a insoluble calcium salt formed spontaneously by the 
combination of Na2CO3 and CaCl2 in aqueous media.  Microspheres of CaCO3 can be 
manufactured in a facile manner by controlling the relative concentrations of the 
precursor salts as well as the temperature of precipitation.135, 136  In addition, material 
present in the precipitation solution can be co-precipitated with the CaCO3 and therefore 
entrapped within the CaCO3 microspheres.
137  This process is mild, and can be utilized 
to encapsulate small and large molecules as well as well as nanoparticles.7, 134, 138, 139 
Due to the ease of manufacture and the naturally charged surface, LbL has been 
widely used in conjunction with CaCO3 microspheres to form microcapsules (Figure 6).
131, 
139-146  PEMs are deposited onto the CaCO3 surface, and once the desired number of layers 
has been deposited, the CaCO3 core can be dissolved in a slightly acidic solution or with 
a calcium-chelating agent to form a capsule. A high degree of control over the physical 
and functional properties of the microcapsules can be achieved; capsule size, thickness, 
permeability, and interfacial interactions can all be designed by choosing the 
appropriately-sized CaCO3 template and materials, as well as controlling the deposition 
conditions (e.g., salt concentration, pH, etc.), number of layers, and the appropriate 
terminating layer. 
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Figure 6: Sequential steps for fabrication of CaCO3 capsules containing molecules 
or particles of interest. 
 
While encapsulation of materials in CaCO3-based capsules and some steps towards 
their use in drug delivery and sensing devices have been explored,143, 145-149 usually, these 
nano-engineered constructs are used or studied as suspensions or, in some cases, 
immobilized onto another surface.  However, little work has been done towards integrating 
these units into larger-scale bulk materials to form complex composites with added 
functionality.150 
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2.4 Applications of injectable materials: optical oxygen and glucose sensing 
technologies 
Oxygen and glucose represent important analytes of interest in the diagnosis and 
continuous monitoring of chronic conditions such as peripheral vascular disease and 
diabetes mellitus.151-155  In particular, diabetes is an area which has great need for the 
development of continuous monitoring technologies.  In the management of diabetes, 
measuring levels of glucose can aid patients and their physicians in making treatment 
and lifestyle decisions that can better keep blood glucose within normal levels.  Better 
control over glucose levels has been shown to reduce the occurrence of and/or minimize 
the long-term side effects associated with diabetes.156, 157  Current state of the art for 
glucose monitoring in people with diabetes involves either ex vivo measurement via 
point-of-care devices or transcutaneous devices such as continuous glucose monitoring 
systems (CGMS).  Point-of -care devices, due to their discrete sampling, do not provide 
the resolution required to determine important changes in analyte levels on a relevant 
time scale.  As a result, long-term side effects of prolonged glucose imbalance, such as 
retinopathy and kidney disease, can occur.157  In contrast, transcutaneous devices 
provide a way to monitor analyte levels continuously, but suffer from inaccuracy and 
short functional lifetimes due to the continuous inflammatory response to the probe.158  
As a result, there has been significant interest in the development of alternatives in the 
form of fully-implantable continuous monitoring systems for minimally-invasive 
measurement of glucose.159 
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Optical sensing of these analytes has many advantages in particular over 
electrochemical sensing, especially in the case of fully-implantable sensors.160, 161  
Optical sensing technologies offer a means to interrogate resident sensing chemistries in 
vivo, with no requirement for physical connection external to the body.  This advantage 
allows for the development of sensors which can be fully implantable, as visible to IR 
light can travel through tissue with minimal impact on the tissue itself.162  While there 
are many optical glucose sensing methods, the one which will be the focus of this 
discussion is based upon oxygen-sensitive phosphors, which alone can serve as optical 
oxygen sensors and have been used to measure oxygen levels in vivo.163-165 
2.4.1 Luminescence lifetime and oxygen sensing 
Luminescence lifetime is the measure of the average dwell time of a 
luminophore’s electrons in a excited state before their return to ground state and 
concurrent release of photons.166  Phosphors in particular have relatively long lifetimes 
when compared to organic fluorophores.  Due to the long residence times, the phosphor 
can be collisionally quenched by oxygen, which interacts with the dye molecule within 
the same time scale as the electron residence time.166  In these cases, the 
phosphorescence lifetime or intensity can be directly related to the oxygen concentration 
by the Stern-Volmer equation (1), where τ and I are the measured phosphorescence 
lifetime and intensity respectively, τ0 and I0 are the phosphorescence lifetime and 
intensity at zero oxygen concentration respectively, and KSV is the Stern-Volmer 
constant, which is specific to the system.166 
(2.1) 
𝜏0
𝜏
=
𝐼0
𝐼
= 1 + 𝐾𝑠𝑣 ∙ [𝑂2] 
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Oxygen sensing-phosphors can be incorporated into a variety of materials, but 
the KSV of the material will be altered based upon the nature of the interaction between 
the phosphor and quencher.166 
2.4.2 Enzyme-based systems for glucose sensing 
Highly-specific optical glucose sensors have been developed by McShane et al. 
utilizing the enzyme glucose oxidase along with a long-lifetime oxygen-sensitive 
phosphor (Figure 7).132 
 
 
Figure 7: Optical enzymatic sensing chemistry utilizing glucose oxidase (GOx) and 
oxygen-sensitive dye.  As glucose is consumed by the enzyme, oxygen levels 
decrease, causing the dye to become less quenched, increasing intensity and lifetime 
of the phosphorescence.167 
 
As glucose is consumed by glucose oxidase in the sensor, oxygen concentration 
is diminished.  This results in a proportional increase in phosphorescence lifetime and 
intensity, both of which can be measured optically.  Because this system is light-based, 
the material can be interrogated through the skin, with no need for transcutaneous 
connection.  This makes glucose sampling non-invasive, unlike current commercially 
available electrochemical devices.  Additionally, the sensing elements (enzyme and dye) 
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can be immobilized in a variety of architectures to suit the application. For example, this 
sensing chemistry can be immobilized in microparticles, multilayer nanofilms, or in 
larger slab materials.168-170 
2.5 Multianalyte sensors and multifunctional systems 
As biomaterials, sensing technologies, and our understanding of the intricacies of 
chronic disease have advanced, there has been increasing interest in the use of 
multianalyte and multifunctional systems.171-173  These systems perform multiple 
functions such as the measurement of multiple analytes (multianalyte sensors) and/or the 
application of therapeutics (mutlifunctional).  Utilization of closed-loop systems 
involving sensing of important analytes and the application of therapeutics, such as with 
the artificial pancreas, is the ultimate goal for treatment and monitoring of chronic 
disease.174 
2.5.1 Multianalyte/mulitmodal sensing 
Multianalyte sensing involves the sensing of multiple molecular species 
simultaneously.  Though this can be done using multiple sensors and multiple devices, in 
the ideal case, a single device would produce the measurements.  However, in a single 
device, there are limitations to utilizing a single sensing mode.  Specifically, using a 
single sensing mode, such as fluorescence intensity, makes the separation of individual 
analyte signals difficult in a system where sensing chemistries are in close proximity to 
one another.  Sensing chemistries designed to produce changes in a particular 
transduction mechanism need to be different from one another and interfere minimally.  
One approach to doing this is to utilize multiple sensing modes (multimodal).  This 
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could involve the use of any number of different transduction mechanisms, but in the 
case of fully implantable sensors, optical methods have clear advantages.132, 171  Utilizing 
multiple modes such as fluorescence intensity, Raman spectroscopy, or phosphorescence 
lifetime, signals from different analytes or the simultaneous measurement of the same 
analyte can be performed.  In these systems, the primary challenge is the 
coimmobilization and optimization of each different sensing chemistry within a single 
sensor.  Despite the challenges, the development of such multianalyte sensors has 
enormous potential for diagnosis, monitoring and prediction in chronic conditions, as 
well as for individualized medicine.175 
2.5.2 Multifunctional implants 
Smart, multifunctional implants represent the end goal of implantable sensor and 
therapeutics.  Individualized medicine will need to have technologies that gauge the 
effectiveness of treatments or provide custom treatments to produce better outcomes.  
Closed-loop systems could allow for much tighter regulation of disease states and better 
management of adverse conditions, and multianalyte sensors could provide new insight 
into the diagnostic markers in the development of chronic disease and effective 
treatments.  To date, while there has been interest in producing multifunctional sensing 
and therapeutic devices, none have made it into the hands of patients.  
Due to the great potential for impact in the management of chronic disease by 
utilizing multifunctional implants, I have proposed a composite material, made from 
calcium carbonate, polyelectrolyte multilayers, and alginate, in which multiple sensing 
or therapeutic elements can be encapsulated within a single, injectable matrix.  This 
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system utilizes the tunable qualities of polyelectrolyte multilayers, the material 
encapsulation qualities of calcium carbonate, as well as the biocompatibility and mild 
gelation properties of alginate.  As this material has never before been characterized, the 
basic properties of the material required investigation.  To prove the composite’s ability 
to function as an injectable, multianalyte sensing platform, the composite was 
characterized for material encapsulation potential, gelation and mechanical properties, 
and sensor response characteristics, each of which are discussed in the follow sections. 
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3. MICROPOROUS ALGINATE COMPOSITE (MPAC) FABRICATION* 
 
Calcium carbonate microspheres in combination with polyelectrolyte multilayers 
have been widely utilized to house sensing chemistries and other molecules for 
therapeutic and diagnostic purposes.122, 130-137  Capsules have the advantage over other 
immobilization techniques because they allow the free movement of encapsulates within 
them (important for affinity or binding chemistries) while allowing for a selective 
permeability of their walls.142, 146  However, injection of capsules alone into the 
subcutaneous space (a common target region for injectables) has drawbacks, with the 
primary pitfalls being the potential for phagocytosis and migration of capsules from the 
original site.176  Therefore, it is desirable to provide extra structure or linkage between 
capsules to mitigate this risk.  There are several examples of carrier materials for 
microsphere injection, including the natural extracellular matrix-like materials collagen, 
hyaluronic acid and alginate.176  These materials serve only to separate particles and ease 
the injection of microspheres, and do not provide significant, long-term mechanical 
support once the solution is injected.  It is therefore desirable to create a crosslinked 
network in the carrier solution after injection, so that a mechanically stable support can 
be provided to the capsules. 
                                                 
*Parts of this section have been reprinted from J. R. Roberts, D. W. Ritter and M. J. McShane, Journal of 
Materials Chemistry B, 2013, 1, 3195-3201 – Reproduced by permission of The Royal Society of 
Chemistry. 
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Alginate has been used as a biocompatible carrier material in a wide variety of 
applications.  However, similar to the capsules, ungelled alginate carrier can migrate (or 
be cleared) from the site of interest.176, 177  Alginate hydrogels can be formed based upon 
the addition of calcium ions to the system.  This can be accomplished by utilizing 
CaCO3 and GDL in an internal gelation mechanism.
68  However, in order to create 
alginate hydrogels with significant mechanical integrity, enough calcium must be 
provided to create a reasonable number of crosslinks.  When using large amounts of 
CaCO3, gelation can occur extremely quickly making injection more difficult. 
In order to create an injectable system that has the advantages of CaCO3-based 
capsules and gelled alginate, a composite system utilizing nanofilm-coated CaCO3 and 
alginate was conceived.  It was hypothesized that addition of nanofilms to the calcium 
carbonate would allow simultaneous, controlled gelation of the alginate while retaining 
materials of interest within microcapsules inside the alginate matrix. The resulting 
composite would be a polymer matrix material that contains diffusion-controlled regions 
that could serve as “microreactors” or drug depots that could be injected and remain in 
place for a reasonable period of time (Figure 8). 
 
 
Figure 8: Schematic of the gelation process of MPAC hydrogels. 
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Microporous alginate composite (MPAC) hydrogels accomplish this by use of 
delayed diffusion of crosslinking calcium ions into the alginate matrix.  The addition of 
nanofilms to the calcium carbonate microspheres causes this delayed diffusion, but also 
serves to create pores in the composite which could contain functional materials such as 
drugs, biomolecules, or nanoparticles.  However, this system has never been attempted 
or evaluated, and so the basic assumptions about the functional properties (pore 
formation and nature, material encapsulation and retention, environmental interaction) of 
the composite were evaluated. 
3.1 Theory and methods 
The initial characterization of MPAC gels focused on the ability of the material 
to form in a predictable way and perform basic application functions.  In order to 
determine the feasibility of MPACs for use as an injectable sensor and therapeutics 
depot, several different properties of the material were evaluated. 
Firstly, morphological differences of alginate made with and without 
polyelectrolyte-coated CaCO3 microspheres were compared.  Scanning electron and 
confocal microscopy were used together to determine the basic structural properties of 
the composite.  Scanning electron microscopy provides a high resolution view of the 
macrostructure of the composite (including the alginate and the polyelectrolyte 
capsules), while confocal imaging provides a means to visualize material within the 
pores of a fully-hydrated composite. 
In order to prove the ability of the composite system to encapsulate and retain 
functional material, model materials including a model macromolecule (bovine serum 
 27 
albumin, BSA), nanoparticles (FluoSpheres), and enzyme (glucose oxidase, GOx) were 
incorporated into the composite via loading of the material into the CaCO3 microspheres 
by coprecipitation.  Material to be encapsulated was first labeled with fluorescent tags 
for visualization and quantification.  Due to its high resolution and reduction of 
background fluorescence, confocal microscopy was utilized to visualize the tagged 
material within the hydrogels fabricated with and without polyelectrolyte multilayers 
and determine if the tagged material was confined to the defined volume of the pores in 
the case of the composite.  Standard fluorescence microscopy, which has much faster 
image acquisition than confocal microscopy, was performed to visualize movement of 
encapsulated nanomaterials within the polyelectrolyte pores to confirm that the pores of 
the composite allow the free movement of encapsulated material after dissolution of the 
template (an important property for binding chemistries).  In both cases, utilizing 
fluorescence microscopy allows for the real-time visualization and characterization of 
the fully-hydrated system.   In addition to direct visual observation, encapsulated 
macromolecules were confirmed to be retained in the hydrogels by exposing the 
composites to excess buffer and sampling the external environment over time for the 
presence of fluorescent material via fluorescence spectroscopy.  
As a final measure of feasibility, apparent activity of the encapsulated model 
enzyme was measured by colorimetric assay to show that catalytic activity of 
encapsulated material.  While not a direct measure of specific enzyme activity, the 
measurement of activity from a composite hydrogel does confirm that the encapsulated 
enzyme can react with substrate supplied from outside the bulk material, and retains a 
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significant portion of its original activity.  This is important, as each process step in the 
manufacture of the composite, including coprecipitation/adsorption on the CaCO3 
surface and dissolution by GDL, could potentially cause inactivation of the enzyme due 
to denaturation or chemical reaction.  Retention of enzyme activity is crucial to the 
function and stability of enzyme-based sensing chemistries, and so confirmation of 
formulation stability is essential. 
3.1.1 Materials 
Poly(sodium 4-styrenesulfonate) (PSS, average Mw = 70,000 Da), 
poly(allylamine hydrochloride) (PAH, average Mw = 51,495 Da), rhodamine B 
isothiocyanate (RITC, mixed isomers), albumin from bovine serum (BSA, >99% by 
agarose gel electrophoresis, ca. 66 kDa), alginic acid sodium salt from brown algae (281 
cps for a 2% aqueous solution at 25 °C), and peroxidase from Amoracia rusticana (type 
II, 188 U/mg solid) were obtained from Sigma and used without further purification. 
Glucose oxidase from Aspergillus niger (GOx, 257 U/mg solid, 71.1% protein by 
Lowry, ca. 160 kDa) was obtained from BBI Enzymes. FluoSpheres® (2% solids, 
carboxylate-modified microspheres, λex = 505 nm, λem = 515 nm) were obtained from 
Invitrogen. 
3.1.2 Calcium carbonate coprecipitation 
All calcium carbonate microspheres utilized in these initial experiments were 
prepared by precipitation and growth resulting from the reaction of the two soluble salts 
Na2CO3 and CaCl2.  Material present in the solution prior to precipitation will be co-
precipitated inside the microspheres resulting in “loaded” microspheres.139  Briefly, 
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loaded CaCO3 microspheres were prepared by adding 8 mL CaCl2 (0.25 M) to 8 mL 
Na2CO3 (0.25 M) containing 4 mg/mL PSS and the material to be encapsulated (ca. 1 
mg/mL rhodamine-labeled BSA (RITC-BSA), 24 nm FluoSpheres at 0.01% solids, 100 
nm FluoSpheres at 0.01% solids, or 200 nm FluoSpheres at 0.01% solids).  PSS is 
normally added to stabilize the surface of the CaCO3 microspheres.
178  However, for 
CaCO3 microspheres containing GOx, the Na2CO3 solution consisted of 8 mg/mL GOx 
only (i.e., no PSS) as the polyelectrolyte greatly inhibits encapsulation of materials with 
high adsorptive potential.  After addition of the CaCl2, the solution was stirred 
vigorously for 30 s, after which time the agitation was removed and the particles were 
allowed to mature under static conditions for 12.5 min.  The suspension was centrifuged 
(500g, 60 s) and the supernatant was removed.  The microspheres were then rinsed three 
times with deionized water prior to further processing. 
3.1.3 Layer-by-layer deposition 
PEMs were deposited onto the loaded CaCO3 microspheres using electrostatic 
LbL self-assembly, in which oppositely charged polyelectrolytes are deposited onto the 
particle surface in alternating fashion (Figure 9).57 
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Figure 9: Left: Schematic of electrostatic adsorption process.  Right: Example zeta 
potential data for particles coated with alternating polyelectrolyte. 
 
For the initial study, commonly used polyelectrolytes, poly(4-styrene sulfonate) 
(PSS) and poly(allylamine hydrochloride) (PAH) were utilized as these materials are 
widely characterized and a staple of previous work within our laboratory.113, 132, 133, 179  
To deposit layers, microspheres were suspended in polyelectrolyte solutions (PSS or 
PAH at 2 mg/mL containing 0.5 M NaCl in deionized water) for 12 min, rinsing with 
deionized water between each deposition step to remove unbound polyelectrolyte.  PSS 
was deposited initially, and then PAH and PSS were alternated until 10.5 bilayers of 
PSS/PAH were deposited.  Successful LbL deposition on the particles was confirmed via 
zeta potential measurements. 
3.1.4 Alginate internal gelation 
Based on the findings of Kuo and Ma for maximum strength internal 
ionotropically gelled alginate,55 the CaCO3: carboxylic acid (from alginate): GDL molar 
ratio was maintained at 1:0.27:2 for all alginate hydrogels.  A 16.8 mg/mL solution of 
CaCO3 microspheres (250 µL, PEM-coated or uncoated) was thoroughly mixed with 500 
µL of 3% (w/v) alginate.  To this solution, 250 µL of 29.8 mg/mL GDL was added. 
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After further mixing, the solution was placed into the appropriate mold and allowed to 
gel for 24 h.  Figure 10 and Figure 11 schematically illustrate the process of forming 
microporated alginate (MPA) hydrogels and depositing them into molds respectively. 
 
 
Figure 10: Schematic illustrating the MPAC fabrication process.  CaCO3 particles 
are precipitated, coated in polyelectrolytes (left), and then mixed with alginate and 
GDL to form the composite (right). 
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Figure 11: Molding of MPAC gels utilizing Teflon spacers.  Precursor solution is 
deposited in the molds and allowed to completely gel (left).  Gelled MPAC slabs 
(right) can then be removed from the mold and samples can be tested for 
mechanical and functional properties. 
 
3.1.5 Physical characterization of microspheres, microcapsules, and hydrogels 
Alginate hydrogels constructed with PEM-coated and uncoated CaCO3 
microspheres containing RITC-BSA or FluoSpheres were cast between two glass slides 
with 0.03” Teflon spacers for electron and optical microscopy (Figure 11).  A benchtop 
scanning electron microscope (JEOL model JCM-5000 NeoScope) was used to image 
microcapsules, PEM-coated and uncoated CaCO3 microspheres, and hydrogels 
constructed using CaCO3 microspheres.  Samples were placed on conductive tape, air-
dried at room temperature for 24 hours, and sputter-coated with a thin layer of gold to 
prevent charging. Samples were held under high vacuum and an accelerating voltage of 
10 kV was used when collecting images. 
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Optical micrographs were obtained using a confocal microscope (Leica model 
TCS SP5) equipped with a 63x oil immersion objective.  An Ar ion laser (λem = 488 nm) 
was used to excite the FluoSpheres, while a HeNe laser (λem = 543 nm) was used to 
excite the RITC-BSA; in all cases in which hydrogels were imaged, the pinhole diameter 
was minimized to eliminate out-of-focus light from the scattering samples.  A second 
confocal microscopy system (Leica model TCS SP5-RS) equipped with a high-speed 
resonant scanner and a 63x water immersion objective was used to collect a z-stack of an 
MPA hydrogel containing 100 nm FluoSpheres.  ImageJ was used to produce 
reconstructions of the images. An epifluorescence microscope (Nikon model Eclipse 
TE2000-U) equipped with a monochromatic camera (Photometrics model CoolSNAP 
HQ2) was used to collect the video demonstrating the 200 nm FluoSpheres moving 
within the microcavities of the alginate hydrogel. 
3.1.6 Release and retention of macromolecules 
Hydrogels made with PEM-coated and uncoated CaCO3 microspheres loaded 
with RITC-BSA (100 µL each) were cast into individual wells of a 96-well microplate. 
After the initial gelation period of 24 h, an extreme excess of GDL (100 µL of 0.1 M) 
was added to each hydrogel-containing well to ensure full dissolution of the CaCO3.  
After 30 min, the GDL solution was removed and placed in an empty well, and 100 µL 
of release buffer (i.e., 0.1 M HEPES, pH 7) was added to the alginate hydrogel-
containing well.  After the appropriate incubation time (0.5, 1, 2, 4, 24 and 48 hours), 
release buffer from each sample was then removed and placed in an empty well, and 
fresh buffer was added to the wells containing the alginate hydrogels.  Fluorescence 
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intensity (λex = 560 nm, λem = 590 nm) was measured for each sample and time point 
(including the first GDL wash) using a microplate reader (Tecan model Infinite F200).  
3.1.7 Encapsulated enzyme activity 
Activity assays on MPAC hydrogels were performed using an enzyme-coupled 
colorimetric assay.180  Equations (3.1) and (3.2) represent the two enzymatic reactions 
utilized.  In these reactions, the production of oxidized o-dianisidine at substrate 
saturation produces a linear change in 500 nm absorbance of the solution over time 
(Figure 12), with the slope of the linear portion representing the apparent activity of 
GOx in the matrix.  It is important to note that the apparent activity represents a 
convolution of enzyme concentration, specific activity and diffusion differences.  These 
differences cannot be separated in the complex architecture of the composite. 
 
(3.1) β-D-Glucose + O2 + H2O ⟶ D-Glucono-1,5-Lactone + H2O2 (GOx) 
(3.2) H2O2 + o-dianisidine (reduced)  ⟶ o-dianisidine (oxidized) (POx) 
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Figure 12: Representative data collected from activity assays with o-dianisidine.  
Slope of the linear portion of the curve represents apparent activity of the material 
and is a result of a convolution of enzyme concentration, specific activity and 
diffusion differences. 
 
MPAC hydrogels made with PEM-coated CaCO3 microspheres containing the 
model enzyme GOx (100 µL each) were cast into individual wells of a 96-well 
microplate.  After 24 h gelation time, reaction cocktail containing the assay chemistry 
was added to the gelled MPACs within the microplate and assayed.  Briefly, 200 µL of 
the reaction cocktail (0.17 mM o-dianisidine, 1.72% (w/v) glucose, 2 units/mL 
peroxidase in 50 mM sodium acetate buffer, pH 5.1) were added to each well using the 
automated dispensing system on the microplate reader.  All measurements were 
performed at pH 5.1 and 35 °C.  Absorbance of each well was then monitored at 500 nm 
for 10 min, and the slope of the absorbance change was used to determine apparent 
activity. 
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3.2 Results and discussion 
3.2.1 Physical characterization of microspheres, microcapsules, and hydrogels 
Full characterization of MPAC hydrogels compared to those without PEMs 
requires an examination of each of the component parts.  Alginate hydrogels were 
prepared using an adapted internal ionotropic gelation method.68  This method involves 
the use of PEM-coated and uncoated CaCO3 loaded with model materials, allowing for 
direct comparison of the effects of the PEMs.  Initially, materials were loaded into 
CaCO3 microspheres by co-precipitation followed by LbL deposition of PEMs onto the 
loaded microspheres (Figure 10).  Three materials—Rhodamine B-labeled bovine serum 
albumin (RITC-BSA), FluoSpheres, and glucose oxidase (GOx)—were used to produce 
three different types of loaded microspheres representing incorporation of a model 
macromolecule, model nanoparticle, and model enzyme, respectively. 
Before manufacture of alginate hydrogels, microspheres containing RITC-BSA 
were exposed to GDL to confirm particle dissolution and demonstrate capsule integrity. 
Figure 13 shows PEM-coated CaCO3 microspheres containing RITC-BSA exposed to 
deionized water (Figure 13A and B) or GDL (Figure 13C and D).  While particles 
exposed to water remain solid, complete dissolution of the CaCO3 template by GDL is 
evident by electron microscopy (Figure 13C); the microcapsules, which are composed of 
PEMs that remain after GDL treatment, appear collapsed due to dehydration of the once 
solvent-filled core.  Fluorescence microscopy confirms that the microspheres contain 
RITC-BSA (Figure 13B), and that the encapsulated material is retained within the 
microcapsules following GDL exposure (Figure 13D). 
 37 
 
Figure 13: SEM micrographs (left) and confocal images (right) of coated CaCO3 
microspheres (top) and polyelectrolyte multilayer capsules (bottom). 
 
After determination of capsule integrity, CaCO3 microspheres with or without 
polyelectrolyte coatings were used to fabricate alginate hydrogels.  Resulting gels were 
compared using SEM and confocal microscopy.  Figure 14 illustrates the remarkable 
difference between alginate hydrogels formed using uncoated (Figure 14A-D) and PEM-
coated (Figure 14E-H) CaCO3 microspheres containing RITC-BSA.  When uncoated 
CaCO3 microspheres were used in the manufacture of alginate hydrogels, no noticeable 
pores were observed in the electron micrographs (Figure 14A-C).  Instead, they exhibit a 
smooth appearance with some wrinkling due to dehydration.  
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Figure 14: SEM micrographs of alginate hydrogels fabricated with no 
polyelectrolyte multilayers (PEMs) on CaCO3 (A-C) and with PEMs (E-G).  
Bottom: Confocal images of the same alginate gels fabrication with uncoated 
CaCO3 (D) and coated CaCO3 (H). 
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The nonporous nature of the hydrogels manufactured with uncoated 
microspheres is expected, as this is similar to the internal gelation mechanism employed 
by Kuo and Ma, which resulted in homogenous alginate hydrogels.68  When these 
hydrogels were inspected using confocal microscopy immediately after gelation, 
fluorescent material can be found in close proximity to where microspheres were 
dissolved (Figure 14D).  However, these patches have undefined boundaries due to the 
free diffusion of material in the alginate.  This can be seen more clearly in Figure 15, 
where fluorescence intensity within hydrogels made with coated CaCO3 is concentrated 
in distinct points (right) while intensity within uncoated CaCO3 hydrogels is not.  It is 
noteworthy that after a period of hours, distinct patches of fluorescent material can no 
longer be found in hydrogels formed using uncoated CaCO3 (data not shown). 
 
 
Figure 15: Fluorescence intensity maps of alginate hydrogels made with uncoated 
CaCO3 (left) and coated CaCO3 (right). 
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This absence of visible fluorescence further demonstrates the free diffusional 
nature of the macromolecule in the matrix, which eventually results in the complete loss 
of material from the bulk alginate into the surrounding solution.  In contrast, when PEM-
coated CaCO3 microspheres were used in the manufacture of alginate hydrogels, a 
clearly distinguishable microporous structure was observed (Figure 14E-G).  Upon 
dehydration of the MPAC hydrogels in preparation for electron microscopy, they 
exhibited a wrinkled morphology with randomly distributed micropores.  In confocal 
micrographs, the encapsulated RITC-BSA appears to occupy distinct regions of the 
hydrogel within defined boundaries (Figure 14H), demonstrating confinement of the 
fluorescent macromolecules within the micropores.  
MPAC hydrogels manufactured with PEM-coated CaCO3 microspheres 
containing FluoSpheres had a comparable microporous structure to that of hydrogels 
containing RITC-BSA (Figure 16); however, the PEM-coated pores did not fully 
collapse under vacuum as in the RITC-BSA-containing MPAC gels, presumably due to 
the greater volume of encapsulated material. 
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Figure 16: SEM micrographs (left) and confocal images (right) of MPAC gels 
fabricated with 100nm Fluospheres (top) and 200nm Fluospheres (bottom). 
 
As with RITC-BSA-loaded MPACs, confocal micrographs of FluoSphere-loaded 
MPAC display distinct regions of fluorescent material (Figure 16), indicating 
confinement within the PEM pores.  Additionally, three-dimensional reconstruction of 
confocal images of a MPAC hydrogel containing the FluoSpheres demonstrates the 
distribution of PEM-lined micropores within the alginate matrix and the confinement of 
the encapsulated material within those pores (not shown).  Utilizing non-confocal 
fluorescence microscopy, free movement of the nanoparticles was confirmed by 
observation of their random motion within the micropores of the MPAC hydrogels (not 
shown). 
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3.2.2 Release and retention of macromolecules 
While it was qualitatively observed in the previous section that macromolecules 
(RITC-BSA) are retained within the pores, a quantitative assessment of retention was 
required to confirm the observation.  It is expected from previous work with alginate that 
large macromolecules can diffuse through the alginate matrix.62  As such, alginate gels 
fabricated with uncoated calcium carbonate spheres were expected to release protein into 
the local environment.  Polyelectrolyte multilayers, however, have been shown to 
exclude large molecules from passage through them.113-115  To evaluate the release of 
encapsulated macromolecules from the alginate hydrogels and determine the effects of 
PEM coatings on this behavior, hydrogels prepared with PEM-coated and uncoated 
CaCO3 microspheres loaded with RITC-BSA were cast into wells of a microplate. 
Release of the labeled macromolecule into the surrounding media was then monitored 
over a period of 55 h. 
Alginate hydrogels formed using PEM-coated CaCO3 microspheres loaded with 
RITC-BSA showed significantly improved retention of the encapsulated material as 
compared to hydrogels formed using uncoated microspheres (Figure 17, left).  Release 
of RITC-BSA from hydrogels formed using uncoated microspheres was approximately 
50 times higher than the release observed from hydrogels formed using PEM-coated 
microspheres.  However, in the ideal case in which PEM coatings are completely devoid 
of defects, no release of the encapsulated macromolecules from the microcapsules is 
expected. 
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Figure 17: (a) Normalized release characteristics of alginate hydrogels fabricated 
with uncoated CaCO3 (○) and coated CaCO3 (□).  (b) Release characteristics when 
normalized to each sample.  Error bars represent 95% confidence intervals (n=4). 
 
The similar shape of the individually normalized curves (Figure 17, right) 
suggests similar transport behavior (i.e., similar diffusional characteristics of the RITC-
BSA through the bulk alginate) in both types of hydrogels.  This can be confirmed 
mathematically by utilizing Fick’s Laws of Diffusion.  In both alginate gels, the same 
concentrations of particles were used, and so the concentration of encapsulated material 
is the same, as uncoated particle containing materials were simply coated in 
polyelectrolyte after fabrication.  Therefore, the same quantity of material could 
potentially be released from both systems.  Fick’s Second Law states: 
(3.3) 
𝑑𝜑
𝑑𝑡
= 𝐷∇2𝜑 
Here, the change in concentration of the diffusing material is proportional to the 
concentration gradient 𝛻𝜑, and the diffusivity D.  In the case of the uncoated versus 
coated MPAC systems, two D values could be assumed: D2 represents the diffusivity of 
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the material through alginate matrix, and D1 represent the diffusivity of material through 
the polyelectrolyte.  In order to determine the change in material outside the alginate, the 
following simple equation can be applied to the case of uncoated alginate:  
𝑑𝜑
𝑑𝑡
= 𝐷2∇
2𝜑. 
In this specific case, as material diffuses out of the alginate, the gradient 𝛻𝜑 
decreases over time, as there is a set amount of total material and a set amount of 
volume.  As a result, 
𝑑𝜑
𝑑𝑡
 decreases over time, causing the release behavior to follow an 
exponential decay behavior, where 
𝑑𝜑
𝑑𝑡
→ 0 as t→∞ observed in Figure 17.  Additionally, 
the end concentration will trend to the total amount of material over the fixed volume.  
In the case of PEM-containing alginate, the change in concentration of the diffusing 
material is subject to a more complicated system in which there is a diffusion barrier 
created by the polyelectrolyte multilayers.  This adds a considerable amount of 
complexity to the system, but can be simplified by treating the system as two 
components, where there is a boundary condition immediately outside the nanofilms.  In 
this case, there are two different diffusion equations: 
𝑑𝜑2
𝑑𝑡
= 𝐷2∇
2𝜑2 and 
𝑑𝜑1
𝑑𝑡
= 𝐷1∇
2𝜑1. 
The change in concentration of material outside the alginate is subject to the diffusivity 
through the alginate, D2, but also the concentration at the boundary, which follows from 
𝑑𝜑1
𝑑𝑡
= 𝐷1∇
2𝜑1.  Therefore, the rate of change in concentration outside the alginate is 
dependent on the rate of change in concentration through the nanofilm.  In the case 
where D1<<D2, equilibration outside the alginate occurs much faster than the rate of 
change at the boundary, and so 𝛻𝜑 → 0, and 
𝑑𝜑1
𝑑𝑡
= 𝐷1∇
2𝜑1 will be rate-limiting and 
will govern the overall behavior.  In the case where D1>>D2, the boundary concentration 
 45 
is at a maximum and 
𝑑𝜑2
𝑑𝑡
= 𝐷2∇
2𝜑2 will govern.  Based upon this simplification, we can 
see that the ideal coated case, in which D1=0, no change in boundary concentration 
occurs, and 
𝑑𝜑2
𝑑𝑡
=0 (there should be no release).  However, in the case where D1>>D2, 
𝑑𝜑
𝑑𝑡
 
will have the same release behavior as the uncoated case, as the boundary essentially 
does not exist.  Since the time-dependent release characteristics of the coated particles 
match those of the uncoated, we can conclude that the case where D2<<D1 is occurring.  
However, the magnitude difference between total amounts released in each case 
indicates that only a proportion of the total material is being released for the PEM-coated 
system.  Therefore, the release of a minuscule amount of material in the hydrogels 
formed using PEM-coated microspheres is likely due to defects in a small fraction of the 
microcapsules (e.g., incomplete film coverage, tearing of the microcapsule wall, etc.) 
where diffusivity through these layers ~0, and the remaining material is locked with 
capsules, where D1>>D2 and 
𝑑𝜑
𝑑𝑡
=0. 
3.2.3 Encapsulated enzyme activity 
The preservation of an encapsulated enzyme’s activity, as well as the system’s 
ability to interact with the surrounding environment is paramount to the utility of the 
system in catalytic and/or biosensing functions.  Therefore, hydrogels prepared with 
PEM-coated CaCO3 microspheres loaded with GOx were cast into wells of a 96 well 
microplate and assayed for relative enzymatic activity to determine whether catalytic 
function is preserved during fabrication of an MPAC hydrogel and whether the 
encapsulated enzyme can react with substrate from outside the hydrogel composite.  A 
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substrate cocktail (i.e., glucose, peroxidase, and the chromophore o-dianisidine) was 
added on top of the GOx-containing MPAC hydrogel, resulting in an observable 
absorbance change within the hydrogel and in the surrounding media (Figure 18). 
 
 
Figure 18: Absorbance change of MPAC gels and surrounding solution as a result 
of addition of reaction cocktail indicating relative GOx activity. Solid line 
represents the average absorbance at a particular time while light blue area 
represents the 95% confidence interval of the absorbance at a particular time 
(n=5). 
 
This absorbance change results from coupled enzymatic reactions catalyzed by 
GOx confined within the microcavities of the hydrogels, as well as peroxidase within the 
media. It is important to notice that the rate of absorbance increase represents the 
apparent activity, and is affected by the concentration and reaction rate of both enzymes, 
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as well as diffusional limitations of the various substrates imposed by the alginate matrix 
and the PEMs.  Figure 18 shows the average and confidence intervals of individual 
points in time for multiple samples, and so shows increasing variability over time due to 
slight differences in slope.  When individual sample curves were fit linearly and 
averaged, the apparent activity was found to be 8.0 ± 0.7 x 10-3 units/mL composite, 
where 1 unit will oxidize 1.0 μmole of β-D-glucose to D-gluconolactone and H2O2 per 
minute.  These data confirm that the encapsulated GOx retains enzymatic activity 
throughout the entire MPAC hydrogel formation process (i.e., from entrapment within 
the CaCO3 microspheres to dissolution of the template by GDL).  Moreover, it 
demonstrates that small molecules can quickly permeate the alginate matrix and diffuse 
into and out of the micropores, while confining the larger, enzymatically-active material 
within the micropores. 
3.3 Conclusions 
The results presented in this section provide the initial evidence of feasibility that 
composite alginate hydrogel materials can be manufactured in a way that produces 
defined regions in which molecules and nanoparticles can be spatially confined.  Unlike 
standard internal gelation techniques which utilize uncoated CaCO3 particles, the 
dissolution of the PEM-coated CaCO3 results in pore formation and material retention.  
Within the composite matrix, PEMs surround the individual pores and form a semi-
permeable membrane which retains large molecules and nanoparticles while allowing 
for small molecules, such as glucose and H2O2, to diffuse in and out of the composite.  
This controllable diffusion barrier is the key advance in the development of injectable 
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alginate materials, as it allows for incorporation of chemistries in a way that allow for 
control of flux-dependent function such as drug elution profile or sensor response 
characteristics. 
While these initial findings are very promising, some additional fundamental 
understanding of the composite system is needed to fully grasp the potential for different 
applications.  For example, the development of in situ-gelling materials for injection 
requires a basic understanding of their gelation kinetics so that gelation times can be 
engineered for the appropriate application.  For this system in particular, it is unknown 
how diffusion barriers will affect the balance between GDL hydrolysis and CaCO3 
dissolution, which could affect gelation times as well as the pH balance during the 
process.  Furthermore, internal gelation techniques have been shown to cause variations 
in hydrogel material properties related to the speed of gelation,68 and so the relationship 
between any changes in gelation kinetics and resulting composite mechanical properties 
needs to be understood.  Once these fundamental properties are understood, further 
development of MPAC systems containing functional elements, such as sensing 
chemistries or therapeutics, can be developed. 
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4. COMPOSITE GELATION AND MECHANICAL PROPERTIES 
 
While it has been shown that MPAC hydrogels can encapsulate and retain 
functional materials, the relationship between PEMs, gelation behavior and mechanical 
properties is as yet unknown.  Understanding gelation kinetics and physical properties of 
injectable matrix materials is fundamental to the further development of functional 
implants containing sensing or therapeutic molecules.  In situ-gelling materials in 
particular require that gelation occur in residence after injection, requiring the precursor 
mixture to remain in liquid form long enough to allow for handling of the precursor prior 
to injection. 
As described in Section 2, alginate transitions from liquid solution to hydrogel in 
the presence of calcium ions.  Exposure to calcium can come from externally applied 
calcium (external gelation) or from an insoluble salt within the alginate liquid (internal 
gelation).  Fabrication of alginate hydrogels by either external or internal gelation is 
highly dependent on the diffusion of calcium ions to the binding sites within the alginate.  
In the case of external gelation, the gelation of the material results simply from the 
movement of added calcium ions from the outside of the alginate through the pregel.  
For internal gelation, the relationship is much more complicated.  The internal gelation 
mechanism utilizes insoluble salts, such as CaCO3, that can be dissolved via acid 
hydrolysis to release ionic crosslinkers.  CaCO3, a commonly utilized salt, aids in 
internal gelation according to several simultaneous processes including the following 
reactions: 
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(4.1) Glucono-δ-lactone + H2O 
k1([OH−])
↔      Gluconate− + H+ (hydrolysis) 
(4.2) CaCO3 
k2([H
+])
↔      Ca2+ + CO3
2− 
(4.3) CO3
2−+H+ 
k3
↔  HCO3
− 
(4.4) HCO3
−+H+ 
k4
↔  CO2 + H2O 
The reaction (4.1) is a relatively slow reaction that is catalyzed by the presence of 
acid or base present in the solution.  The reaction rate in this case is then dependent on 
the pH of the solution, where increasing difference from pH 7 results in a faster reaction.  
In addition to the hydrolysis of GDL, There are three equilibrium reactions of carbonates 
(4.2-4.4).  Each one of the equilibrium reactions has an associated rate constant (kx) for 
both forward and backwards directions that is dependent on the concentration of each of 
the constituents on either side of the equilibrium reaction.  What can be taken from the 
carbonate equilibrium reactions is that if hydrogen ion concentration increases, CaCO3 
will tend to break down and form carbonates of lesser charge.  This is the basic 
mechanism of internal gelation, as the hydrolysis of GDL produces hydrogen ions 
which, in turn, fuel the dissolution of CaCO3 and the production of calcium ions.  
Previous work has shown increases in gelation time when comparing internal to external 
gelation.68  Thus, it can be concluded that reaction (4.1) plays a central role in standard 
internal gelation techniques.  However, while the standard internal gelation mechanism 
is driven by the reactions previously described, MPAC gelation is not.  MPAC structure 
creates a diffusion barrier between sources of GDL/hydrogen ions in the alginate from 
the calcium carbonate source of the microparticles.  In MPACs, PEMs provide these 
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barriers, which have been shown to significantly slow transport of small molecules and 
ions.114, 115, 134, 181  Therefore, MPAC gelation, while certainly influenced by GDL 
hydrolysis and the dynamic carbonate equilibrium, should also be dependent on the 
diffusion of materials in and out of the particles/pores.  This slowed transport of ions 
through the films is hypothesized to result in increased gelation time of MPAC gels. 
As with any injectable material, tissue near the implanted material must be 
protected from exposure to hostile conditions such as toxic substances, excessive heat or 
acidity.  Fortunately, alginate gelation utilizing calcium is by nature a mild process that 
does not produce heat or toxic byproducts.  For the internal gelation of alginate, calcium 
carbonate and GDL levels are usually stoichiometrically balanced as per reactions (4.2-
4.4) to produce near neutral conditions at equilibrium.68  However, the nanofilms utilized 
in MPAC fabrication have the potential to cause disruption in the intermediate 
equilibrium kinetics resulting in undesirable transient drops in pH during the gelation 
process.  Thus, it is important to study this process and quantify these effects to ensure 
the retention of mild gelation conditions. 
In addition to the effects of nanofilms on transient properties of the gelation of 
MPACs, films may also contribute to the mechanical properties of the fully-gelled 
composite.  Desired final mechanical strength of an in situ gel depends, to a great extent, 
on the application.  To develop a material for use in a variety of applications, it would be 
ideal to have control over the mechanical strength in a facile manner.  Alginate 
mechanical properties are generally controlled through crosslink organization and 
density from a variety of means.55  Specifically, studies have indicated that increasing 
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gelation times of alginate material (internal vs. external gelation), while keeping the 
overall calcium quantity the same, results in more homogenous gelation (more uniform 
crosslink density) and hence greater mechanical strength of the bulk.68  It would 
therefore seem plausible that in the case of MPACs, where gelation times would be 
increased beyond those of traditional alginate gels, the alginate would be very 
homogenously gelled and mechanically robust.  However, MPAC gels have added 
mechanical complexity over standard alginate hydrogels as they contain a certain 
volume of pores which should affect the overall mechanical properties of the material by 
increasing the water volume and altering the density.  Therefore, it was hypothesized 
that MPAC gel strength will not only be influenced by gelation times, but also the 
concentration of calcium crosslinker and the resulting increase in porosity. 
Swelling behavior and mechanical attributes of hydrogels are extremely 
interconnected properties.182  Swelling is an important parameter for development of 
functional implants utilizing hydrogels, as swelling can be advantageous or problematic 
depending on the application.183  Hydrogels that swell greatly can effectively lower the 
concentration of molecule(s) within the pores of the hydrogel, which could result in 
undesirable functional changes in the implant such as sensor response changes.  In 
addition, stability of the gel in the long term as well as potential host response to the 
material will be dependent on the swelling behavior and mechanical properties of the gel 
during the transition.  Swelling behavior of alginate, which is commonly influenced by 
crosslink density and gelation parameters, is hypothesized to be different in MPAC gels 
due to their porous nature and delayed gelling kinetics.48, 68, 71, 79 
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4.1 Theory and methods 
To better understand the complex relationship between the addition of nanofilm 
coatings and crosslinker/porosity in MPAC fabrication and the mechanical properties 
and gelation kinetics of the matrix, several sets of experiments were performed at 
various steps in the hydrogel formation.  Small amplitude oscillatory rheological 
measurements were utilized to determine the effects of nanofilm permeability on 
gelation kinetic behavior and composite strength.  Fluorescence assays were used to 
determine transient changes in pH during gelation.  After gelation, swelling behavior of 
MPAC hydrogels was evaluated using gravimetric techniques, and mechanical stability 
of gels immersed in solvent over time was evaluated through immersion dynamic 
mechanical analysis. 
4.1.1 Materials 
Poly(sodium 4-styrenesulfonate) (PSS, average Mw = 70,000 Da), 
poly(diallyldimethylammonium chloride) (PDADMAC, typical Mw range =  100,000-
200,000Da) , poly(allylamine hydrochloride) (PAH, average Mw = 15,000 Da), 
poly(sodium 4-styrenesulfonate-co-maleic acid) (PSS-co-MA, 1:1 monomer ratio, 
average Mw = 20,000 Da), alginic acid sodium salt from brown algae (281 cps for a 2% 
aqueous solution at 25 °C), and 8-hydroxypyrene-1,3,6-trisulfonic Acid (HPTS) were 
obtained from Sigma and used without further purification.  
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4.1.2 MPAC fabrication 
4.1.2.1 CaCO3 microsphere preparation 
CaCO3 microspheres were prepared by precipitation.  Briefly, Na2CO3 (0.25 M, 
8mL) containing 4 mg/mL PSS was stirred vigorously in a 25 mL beaker with a 10 mm 
triangular stirbar.  CaCl2 (0.25 M, 8 mL) was then added to the solution under stirring.  
The solution was stirred for 30 seconds after mixing, and then agitation was removed 
and the colloid was allowed to rest for 10 minutes thereafter for particle maturation.  
Particles were then collected, centrifuged and washed in 5 mM Na2CO3 pH 8.0 prior to 
layer-by-layer deposition. 
4.1.2.2 Polyelectrolyte multilayer deposition 
The first five bilayers of particles were constructed using the strong positive 
polyelectrolyte PDADMAC and the strong negative polyelectrolyte PSS in the absence 
of additional counterions to ensure strong base surface charge with minimal charge 
sheilding.  Additional layers after these first five bilayers were constructed using PAH 
and PSS-co-MA as the weak positive and negative polyelectrolytes respectively for the 
purpose of creating greater diffusion limitation.  Briefly, the particle suspension in 1 mL 
of 5 mM NaHCO3 (pH 8.0) was centrifuged at 500 g for 30 seconds and resuspended in 
1 mL 5 mM NaHCO3 (pH 8.0) with 20 mg/mL PDADMAC and allowed to incubate for 
30 seconds.  The particles were then centrifuged down at 500 g, supernatant removed, 
and washed once with 1 mL 5 mM NaHCO3 (pH 8.0).  The washed particles were 
centrifuged down again and resuspended in 1 mL 5 mM NaHCO3 (pH 8.0) with 20 
mg/mL PSS and allowed to incubate for 30 seconds.  This process was repeated until 
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there were 5 bilayers of PDADMAC/PSS.  After these layers, PAH and PSS-co-MA 
were deposited.  A 1 mL solution of 20 mg/mL PAH in 5 mM NaHCO3 (pH 8.0) was 
added to the packed particles with 5 bilayers, mixed, and allowed to incubate 30 
seconds.  Particles were then centrifuged at 500 g and resuspended in 5 mM NaHCO3 
(pH 7.2).  Washed particles were then centrifuged and resuspended in 5 mM NaHCO3 
(pH 7.2) with 20mg/mL PSS-co-MA and allowed to incubate 30 seconds.  PSS-co-MA-
coated particles were then centrifuged, washed, and resuspended in 5mM NaHCO3 (pH 
8.0).  This alternating process was repeated until the desired number of bilayers was 
achieved.  LbL deposition was confirmed with zeta potential measurements of aliquots 
collected during the LbL process.  Particles to be analyzed were dispersed in 5 mM 
NaHCO3 pH 7.2 for zeta potential analysis.  Particles were labeled by the total number 
of bilayers of polyelectrolyte deposited, including both architecture types (e.g. 5 bilayers 
includes only PDADMAC/PSS, while 10 bilayers includes 5 bilayers PDADMAC/PSS 
and 5 bilayers PAH/PSS-co-MA). 
4.1.2.3 Alginate composite preparation 
Microporous hydrogels were formed by combining PEM-coated calcium 
carbonate microspheres with alginate and GDL.  For all experiments, the molar ratio of 
CaCO3 to GDL was kept constant at 1:2.  Relative levels of CaCO3 and GDL to alginate 
were varied to observe the resulting effect on mechanical and gelation properties.  For 
the purposes of brevity, a molar ratio of 1:0.27:2 of CaCO3:(carboxylic acids in 
alginate):GDL, which was shown to have favorable mechanical properties by Kuo and 
Ma,68 was considered to be 1x, with 2x being twice the molar quantity of CaCO3 and 
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GDL, 3x being three times the molar quantity of these elements, etc.  In all cases, the 
molar quantity of alginate was kept the same.  Gel precursors were made by centrifuging 
the appropriate amount of CaCO3 particles, removing the storage buffer (5 mM 
NaHCO3, pH 8.0), and adding deionized water (200uL).  Alginate (400 µL of 3% (w/v) 
in DI water) was then added and mixed.  GDL solution of the appropriate concentration 
(200 uL) was then added and the solution was mixed vigorously and placed in a mold or 
testing appartus.  For each set of characterization experiments, different fabrication 
parameters including different particle concentrations and numbers of bilayers were 
tested (Table 1). 
 
Table 1: Fabrication parameters tested in gelation studies utilizing small amplitude 
oscillatory measurements (I), pH evolution (II), swelling studies (III), and DMA 
(IV) 
 
 Bilayer 
  5 10 15 20 25 30 
C
o
n
ce
n
tr
a
ti
o
n
 
0.5x II,III,IV II,III,IV II,III,IV II,III,IV II,III,IV II,III,IV 
1x I, II, III, IV I, II, III, IV I, II, III, IV I, II, III, IV I, II, III, IV I, II, III, IV 
2x II,III,IV I, II, III, IV II,III,IV I, II, III, IV II,III,IV I, II, III, IV 
3x II,III,IV I, II, III, IV II,III,IV I, II, III, IV II,III,IV I, II, III, IV 
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4.1.3 Rheology and gelation points 
Measurement of gelation points of crosslinking polymers has historically been 
accomplished utilizing small amplitude oscillatory measurements.  In these tests, 
reacting sample is placed between a rotating cone and a fixed plate (Figure 19). 
 
 
Figure 19: Schematic of a rheology apparatus consisting of a cone and plate. 
 
A strain (γ) is applied in a fixed frequency (ω) sinusoidal form (4.5), while the 
stress (σ) is measured (4.6).  Due to the viscous behavior of viscoelastic materials such 
as gels, the stress will be phase shifted by the angle δ (4.6).  Utilizing the known strain γ, 
measured stress σ, and measured phase shift δ, the complex shear modulus G*(ω) can be 
determined, and its components, storage modulus (G’) and loss modulus (G’’) can be 
extracted (4.8, 4.9). 
(4.5) γ(t) = γo sin(ωt) 
(4.6) σ(t) = σo sin(ωt + δ) 
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(4.7) G∗(ω) = G′(ω) + iG′′(ω) 
(4.8) G′(ω) =
σ0
γ0
cos (δ) 
(4.9) G′′(ω) =
σ0
γ0
sin (δ) 
(4.10) tan(δ) =
G′′(ω)
G′(ω)
 
Storage modulus and loss modulus represent the elastic, or “solid-like”, and 
viscous, or “liquid-like”, components of the shear modulus respectively.  From these 
measured values, we can determine the interval in time when a material transitions from 
a viscous-dominant state to an elastic-dominant state as in polymerization and/or 
gelation of a polymer.  This transition point is known as the gelation point of the 
material, and has been shown to occur when G’= G’’ and tan(δ)=1 (4.10) in materials 
that have a stress relaxation exponents of ½, or when the frequency dependence of G’ 
and G’’ is equal.184, 185 
Rheological characterization was performed utilizing an Anton Paar Physica 
MCR301 with a CP50-1 Cone of 50mm diameter and an angle of 1̊.  MPAC hydrogel 
precursors of different microsphere concentrations and different numbers of nanofilm 
bilayers (Table 1) were mixed and immediately placed on the rheometer.  Small 
amplitude oscillatory measurements were performed with 1% strain and 1Hz frequency 
(linear viscoelastic region).  Crossover of G’ and G’’ was used to determine gelation 
points between sample types based upon the observations of frequency-dependent 
behaviors over time (relaxation exponents at crossover points were observed ≈ ½ and G’ 
and G’’ were observed to have equal frequency dependence at crossover).  Mechanical 
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properties G’, G’’ and tan(δ) values for comparison of end gel strength were determined 
from the same small amplitude oscillatory measurements 80 minutes after fabrication. 
4.1.4 pH changes during gelation 
pH evolution during gelation was monitored utilizing the pH-sensitive dye 8-
hydroxypyrene-1,3,6-trisulfonic Acid (HPTS).  This dye has a single emission peak at 
~512 nm and two different excitation peaks located at ~370/400 nm and ~450 nm 
(Figure 20).  As the pH changes, the peak ratio of HPTS changes in a sigmoidal fashion 
around the isoelectric point, which is near the physiologically-relevant value of ~7.4.  
Due to the dye’s ratiometric nature, differences in excitation source intensity, dye 
concentration or photobleaching have a greatly reduced effect on signal.  This is 
particularly important in a highly scattering system such as the MPAC hydrogel. 
Calibration of HPTS emission ratios for determination of unknown pH within 
MPAC hydrogels requires certain assumptions to be made.  Calibration can be done in 
two ways: calibrating to dye emission in solutions of differing pH, or calibrating to dye 
emission within a hydrogel.  In the first case, the pH of the calibration solutions are 
directly measureable utilizing a pH meter, and so precise pH to emission relationships 
can be determined.  However, emission of the dye from an unknown MPAC sample 
must be assumed to be the same as the solutions utilized in calibration for absolute pH to 
be accurately determined.  In the second calibration method, pH cannot be measured 
directly within the hydrogel, and so pH within the hydrogel must be assumed to be equal 
to the solution containing the hydrogel.  If the pH within the hydrogel differs from the 
solution it resides within, error in calibration will result. 
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To determine pH in unknown hydrogel samples, both calibration curves of the 
dye (solution and in hydrogel) were constructed.  The first calibration was a solution-
phase calibration involving dye in titrated buffers.  HPTS was dissolved in 0.5 M buffers 
ranging from pH 3-11 to a concentration of 25 µM.   Buffered solutions (200 µL) 
containing dye were deposited in 96 well plates and 100 µL of paraffin oil was deposited 
on the aqueous surface to prevent evaporation.  Emission at 512 nm was measured using 
a Tecan model Infinite M200 Pro plate reader utilizing 454 nm and 400 nm excitation 
with a manual gain of 45 and a z position of 20 mm.  The ratio of emission intensities for 
each buffer solution was used to construct a solution-phase calibration curve.  A second 
calibration curve utilized MPAC hydrogels equilibrated in buffer solutions of varying 
pH.  For this, 200 µL of MPAC precursor solutions of the formulation variables 20BL 
and 1x (described above) were deposited into individual wells in a 96 well plate and 
allowed to gel 24 hours.  The gels were removed and placed in 0.5 M buffer solutions 
containing 25 µM HPTS at pH ranging from 3-11.  After 24 hours incubation, gels were 
placed back into the 96 well plates and measured for emission using 454 nm and 400 nm 
excitation wavelengths to construct calibration curves.  Calibration data was fit to a 
curve utilizing a sigmoidal fit of the form 𝑦 =
𝑎
𝑏+𝑒−𝑐∙𝑥
+ 𝑑. 
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Figure 20: Excitation spectra of 8-Hydroxypyrene-1,3,6-Trisulfonic Acid (HPTS) 
measured at the emission peak of 512nm. 
 
For pH determination in unknown samples, PEM-coated CaCO3 spheres were 
suspended in 190 µL DI H2O, and 10 µL of 2 mM HPTS in DI H2O was added to this 
solution.  A 400 µL solution of 3% alginate in DI H2O was added and mixed by vortex.  
A 200 µL aliquot of GDL solution was then added, and the solution was again mixed by 
vortex.  The pH-sensitive pregels (200 µL each) were deposited into 96-well plates and 
100 µL of paraffin oil was deposited on top to prevent evaporation of solvent.  Emission 
of the HPTS (512 nm) from each of its two excitation wavelengths (400 nm and 454 nm) 
was monitored over a period of hours in a Tecan model Infinite M200 Pro plate reader 
with a manual gain of 45 and a z position of 20 mm.  The ratio of the two emission 
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values (454/400 nm) was used along with the fitted calibration curve to determine pH 
within the gelling material. 
4.1.5 Composite swelling 
Hydrogel swelling is a thermodynamic process involving the solvation of the 
polymer chains.  Solvent molecules (water in the case of hydrogels) move into the 
polymer network and associate with the polymer chains.  This process is complex and 
depends on many attributes of the polymer such as hydrophilicity of backbone and side 
groups, polymer flexibility, crosslink density and charge, to name just a few.  The 
swelling behavior for MPAC is particularly important to understand, as it will affect the 
relative spacing of microdomains within the composite (Figure 21).  This has 
implications for the functional aspect of the gels, as distance dependence between 
regions may affect sensor or drug delivery function.  To determine the extent of swelling 
for different MPAC formulations, gravimetric analysis of gelled and swollen hydrogels 
was performed. 
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Figure 21: Schematic of the basic structure of the crosslinked hydrogel network. As 
the hydrogel network swells, distances between pores (∆) become greater. 
 
MPAC hydrogels of different microsphere concentrations and different numbers 
of nanofilm bilayers (Table 1) were mixed and cast between two glass slides separated 
by a 1.5 mm Teflon spacer.  Biopsy punches (2.5 mm) were used to punch individual 
samples from each hydrogel slab.  Gel punches were measured for weight prior to 
swelling (gelled weight) and after 48 hours in 400 µL DI water (swollen weight).  Gels 
were kept at room temperature for the entire experiment.  Swelling ratio, though 
classically defined as swollen weight over dry polymer weight,186 was instead defined as 
the difference in swollen weight and gelled weight over gelled weight as this value better 
represents the property that will be most relevant in an in situ-forming system (drying 
will never occur). 
4.1.6 Gel stability and dynamic mechanical analysis 
Experiments to determine the extent of swelling, while important, do not provide 
an insight into of the mechanical changes within the hydrogel during swelling. During 
swelling, addition of water molecules can cause stretching of the crosslinked polymer 
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chains, increasing the stress on each (Figure 22).  This can manifest as stiffening in the 
macroscale, and can greatly affect the overall mechanical properties of the hydrogel slab 
such as modulus and yield strength.  As the biocompatibility of a material will depend 
on the mechanical properties of the material, it is extremely important to understand 
material stability as a means to improve implant function within various application 
areas inside the body.187, 188  Dynamic mechanical analysis (DMA) provides a way to 
determine mechanical changes in a material during the evolution from one state to 
another, such as in a hydrogel during swelling.  Looking closely at these changes over 
time, inferences about how the hydrogel physical structure is changing can be made. 
 
 
Figure 22: Schematic of the basic structure of the cross-linked hydrogel network. 
As the hydrogel network swells, individual polymer chains become stressed. 
 
Dynamic mechanical analysis involves the cyclic stress or strain of a material.  
This can be compression, tension, torsion or in the case of rheology: shear.  Due to the 
nature of the in vivo environment, materials for implantation are commonly evaluated for 
shear and compression moduli, with shear moduli being derived from rheology and 
 65 
compressive moduli derived from compressive DMA.  The same basic viscoelastic 
characterization principles discussed earlier for rheology apply in compression DMA.  
Utilizing an instrument such as the one depicted in Figure 23, sample slabs can be 
compressed sinusoidally in a strain or stress-controlled manner.  Compression modulus, 
dampin 
g factor and other relevant mechanical information can be extracted over a period 
of time.  In addition, samples can be immersed in liquid during compression and 
evaluated for changes in viscoelastic behavior.  This technique was applied to determine 
the changes in compressive moduli of samples of various formulations of MPAC 
hydrogels. 
 
 
Figure 23: Schematic of the immersion apparatus for dynamic analysis of material 
swelling. 
 
Dynamic mechanical analysis was performed utilizing a Triton Technology TT 
Dynamic Mechanical Analyzer.  MPAC hydrogel precursors were molded between two 
glass slides separated by 1.5 mm Teflon spacers.  Gels were stored in a humidity 
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chamber prior to testing.  MPAC samples were punched from the slab using 6 mm 
biopsy punches and placed on the DMA.  Samples were then analyzed under cyclic 
compression at 1 Hz with dynamic strain control and a static force ratio of 1.1.  Samples 
were immersed in DI water and monitored over a period of hours for changes in 
mechanical properties. 
4.2 Results and discussion 
4.2.1 Rheological measurements 
Rheological measurements were performed on gelling MPAC hydrogels in order 
to determine the effect of increasing polyelectrolyte multilayers on CaCO3 microspheres 
on the gelation times of the composite.  Increasing numbers of bilayers, representing one 
of each positive and negative polyelectrolyte polymer layer, would be expected to 
decrease the permeability of the nanofilm and therefore decrease the flow of molecules 
in and out of CaCO3 microspheres/pores. 
4.2.1.1 Gelation points 
Gels fabricated for rheological measurement can be seen in Figure 24, which is a 
representative example of a 3x gel (maximum porosity) after complete gelation.  Pores 
are dispersed in random fashion within the gelled alginate matrix, as was seen in data 
presented in Section 3. 
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Figure 24: Scanning electron micrographs of 3x MPAC gels used in rheological 
experiments. 
  
Small amplitude oscillatory measurements were performed on MPAC hydrogels 
to determine the changes in G’, G’’, and tan(δ) for gelling samples. In this system, the 
crossover point of G’ and G’’ can represent the gel point if the relaxation exponent at gel 
point is ½ and G’ and G’’ have the same dependence on frequency.  However, unlike 
other polymer systems with thermal or photocrosslinkable gelation, the MPAC system 
cannot be interrupted during gelation and tested over a range of frequencies, as it takes 
several minutes to complete a frequency sweep.  Because of this, only frequency sweeps 
on the slowest gelling system (30BL) could be performed, and only on continuously 
gelling material.  Slopes were approximated and compared to crossover points of G’ and 
G’’ during gelation to determine if these crossover points can be used to approximate 
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gelation point.  Slopes of G’ and G’’ over frequency at different time points were 
compared as well as complex viscosity over time and frequency. In both cases, 
approximation of gelation point is required, as the gelation occurs over a shorter period 
of time than the frequency can be changed.  This results in an apparent nonlinearity in 
frequency dependence.  However, it can be clearly seen from G’,G’’ versus frequency 
(Figure 25) that the gelation point must occur between time points 21 minutes and 27 
minutes, which agrees well with observed crossover points of G’ and G’’ at 23 min.  In 
addition, looking at complex viscosity, it was determined that the approximate slopes 
(relaxation exponent) fit the slopes with time, and determine where the relaxation 
exponent should be ≈0.5 (Figure 26).  In this case, we see again that this approximation 
agrees well with observed crossover point. 
 
 
Figure 25: Frequency sweeps of 1x 30BL MPAC gel during gelation plotted against 
G’ and G’’.  Lines are separated by orders of magnitude for visualization purposes.  
Circles represent G’ while squares represent G’’.  Arrows point to sweeps where G’ 
and G’’ have similar slope values, and hence gel point should occur between these 
sweeps. 
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Figure 26: Top: Frequency sweeps plotted against complex viscosity (η*).  The 
point where the slope of the relationship is 0.5 represents the gel point.  Using an 
interpolation of slope values (bottom), we find this point to be in good agreement 
with transient data of these MPAC gels. 
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MPAC samples fabricated with different numbers of polyelectrolyte bilayers 
show significantly different gelation kinetic behavior (Figure 27). 
 
 
Figure 27: Sample transient data showing the relationship between G’, G’’, and 
tan(δ) as a function of time.  Crossover points of G’ and G’’ are defined as the 
gelation points of the material. 
 
The crossover points of G’ and G’’ are shifted to greater elapsed time (Figure 
28).  This indicates that gelation time is being extended with increasing diffusion barrier 
from the nanofilms.  However, above 20 bilayers of polyelectrolyte, the effect of this 
diffusion barrier seems to fall off. 
G’ 
G’’ 
tan (δ) 
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Figure 28: Crossover points of G’ and G’’, representing the gelation points of 1x 
MPAC gels with varying numbers of polyelectrolyte bilayers.  Error bars represent 
95% confidence intervals (n≥3). 
 
This is an interesting observation, as it might be expected that crossover times 
would continue to increase as diffusion of molecules decreases.  This could partially be 
explained by an observation of the permeability of planar LbL (same formulation) to 
glucose in the next section, where drastic changes in permeability occur from 0 to 5 
bilayers and from 5 to 10 bilayers, but at decreasing magnitude from there on.  While the 
magnitude of diffusivity of carbonates, ions and GDL will be different from that 
observed for glucose, similar trends are expected for these small molecules.114, 115, 181   
Looking at MPAC hydrogels of different concentrations of particles (Figure 29), we see 
that a similar relationship between bilayer number and crossover time is seen for all 
concentrations.  However, as concentration of particles increases, crossover time 
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decreases dramatically.  This makes sense, as MPAC made with larger numbers of 
particles have a larger CaCO3 and GDL concentration and particle surface area.  Larger 
quantities of the crosslinker and increased particle surface areas should correspond to 
higher magnitude and faster release of ions respectively, resulting in faster gelation of 
the alginate. 
 
 
Figure 29: Crossover points of G’ and G’’, representing the gelation points of 10, 20 
and 30BL MPAC gels with varying concentrations of particles utilized in 
fabrication.  Error bars represent 95% confidence intervals (n≥3). 
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4.2.1.2 Mechanical properties 
Shear moduli of gelled MPAC hydrogels was determined utilizing the same 
small amplitude oscillatory measurements as in gelation kinetic experiments.  Gels 
display dependencies on both concentration and bilayer number (Figure 30, Figure 31, 
Figure 32).  However, dependency on concentration is much more marked than bilayer 
number.  Storage and loss moduli both increase with increased concentration up to 2x, 
but then decrease in 3x gels.  Looking at this trend, it is important to recall that 
increasing the concentration of CaCO3 particles not only increases the number of 
crosslinking ions, but also increases the overall porosity of the hydrogel.  These are 
convoluted and opposite effects, and they are not linear.  At a certain concentration of 
ionic crosslinkers (dependent on the concentration and type of alginate), the hydrogel 
will become saturated with crosslinks and no more can be made.  At that point, addition 
of crosslinking ions in the form of CaCO3 microspheres serves only to weaken the gel, 
as it produces higher porosity without any increase in crosslinking.  This effect, which is 
observed in similar porous matrices,189 seems to be occurring between 2-3x 
concentrations, and will be an important consideration for future work that is dependent 
on the mechanical integrity of the MPAC system. 
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Figure 30: Storage modulus, G’, of MPAC gels as a function of differing 
concentrations of particles and different numbers of polyelectrolyte bilayers. 
 
 
Figure 31:  Loss modulus, G’’, of MPAC gels as a function of differing 
concentrations of particles and different numbers of polyelectrolyte bilayers. 
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Figure 32: Damping factor, tan(δ), of MPAC gels as a function of differing 
concentrations of particles and different numbers of polyelectrolyte bilayers. 
 
Dependence of shear moduli upon bilayer number is much less striking than 
dependence upon particle concentration.  However, there is a clear relationship of 
increasing numbers of bilayers resulting in increased shear moduli.  Looking at damping 
factor, tan(δ), it can be concluded that increasing numbers of bilayers decreases the 
elastic behavior of a MPAC.  So, while the MPAC gels with higher numbers of 
polyelectrolyte bilayers have generally increased strength, they display a much more 
viscous behavior overall. 
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4.2.2 pH changes during gelation 
In the alginate internal gelation mechanism, the hydrolysis of glucono-δ-lactone 
in water produces gluconic acid, lowering the pH of the solution.  This drop in pH in 
turn causes the dissolution of the CaCO3 and a subsequent increase in pH.
68  This 
complex interdependent process produces overall changes in hydrogel pH during the 
gelation process.  However, in MPAC gelation, there is the added complexity of 
transport of GDL/gluconic acid and calcium through the nanofilms.  This is the basic 
physical phenomenon responsible for the gelation extension, and this effect alters the pH 
evolution during gelation.  Changes in pH during gelation could have a dramatic impact 
on the utility of MPAC hydrogels for in vivo application.  Ideally, pH values should 
remain near neutral to reduce the stress experienced by tissue near the injection site.  
While the systems are stoichiometrically balanced to remain near neutral, there is a 
possibility that pH evolution during gelation could produce extremes in a severely-
delayed system such as in MPACs. 
Calibration utilizing both solution phase and “in hydrogel” methods can be seen 
in Figure 33.  Both fit methods result in a sigmoidal relationship between emission ratio 
and pH with inflection at ~7.4,which is characteristic of HPTS. 
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Figure 33: Calibration curves for HPTS in solution (black) and in MPAC gels 
equilibrated in buffer solution (red). Top: Full scale from pH 3.5 to pH 10.5.  
Bottom: Region of interest between pH 6.5 and 8.5.  Error bars represent 95% 
confidence intervals (n=3). 
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In the case of the “in hydrogel” calibration, ratios deviate from solution phase 
calibration at pH values outside 6.5-9.5.  This is to be due to deviation between inner gel 
pH and solution pH.  At low pH, it was observed that hydrogels had measurable 
absorbance/excitation at 454nm, which should not occur for HPTS at these apparent pHs 
(Figure 34).  This absorbance difference can be observed macroscopically (Figure 34). 
 
 
Figure 34: Left: Representative excitation scans of solution and MPAC calibrants. 
Right: Observable absorbance differences in gels compared to surrounding 
solutions. 
 
In these calibration samples, the pH inside of the hydrogel is different than the 
solution it is equilibrated within.  As such, this calibration method cannot be utilized for 
pHs below ~6.  This is of little consequence, as HPTS cannot be used effectively to 
measure pH below 6 even in solution, as emission ratios below this value are not 
significantly different from one another.  Within usable and relevant pH ranges (~6 -9.5), 
solution and “in hydrogel” calibrations appear to be very similar (Figure 33, bottom).  
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However, due to the inclusion of accurate and precise calibration points at the low pHs, 
the solution phase calibration fit is a better choice for accurate determination of pH in 
unknown samples and was utilized to determine pH in MPAC samples during gelation. 
Evolution in pH of MPAC hydrogels during gelation display dependence on 
concentration of CaCO3 particles and bilayer numbers (Figure 35).  Change in pH within 
MPAC hydrogels show a consistent tri-phasic pattern during the gelation process for all 
gel types (Figure 35).  Upon mixing, the pH increases to a local maximum for all 
samples except the lowest number of polyelectrolyte bilayers.  This effect is the 
dominant effect in MPAC hydrogels fabricated with higher concentrations of particles.  
As such, this effect is likely due to the release of carbonate ions, as these are more 
numerous in higher particle concentrations, and these ions represent the only source of 
base in the system. 
After the initial increase, the pH evolution then enters a secondary phase, where 
differences between bilayers and particle concentrations are more readily apparent.  
Here, the pH continues to increase to another local maximum, with absolute value at a 
range of pH values dependent on concentration and bilayer numbers.  This phase 
dominates in MPACs fabricated with lower concentrations of particles and lower 
numbers of bilayers.  Though in general, higher concentrations of particles and bilayer 
numbers results in a higher local maximum in this phase.  Additionally, the local 
maximum occurs earlier in the pH evolution for samples prepared with higher 
concentrations of particles and increasing numbers of bilayers.  Due to the increase in 
pH during this phase, it is likely caused by carbonate ions as in the first phase.  
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However, in this case, the release is delayed significantly from the initial burst.  There 
could be several possible reasons for this, including diffusion of the dye into the higher 
pH capsules or a secondary release of carbonate ions due to a time-dependent effect such 
as GDL diffusion or hydrolysis.  Due to the complexity of the system, it is unclear what 
is causing this secondary phase, but it can be inferred that it is dependent on numbers of 
bilayers, and hence diffusion in and out of the hydrogel pores.   
In the final phase of the pH evolution, pH decreases to an equilibrium value for 
all samples.  In nearly all cases, this value is around pH 6.5, but in the cases of 0.5x, the 
value approached depends greatly on bilayer number.  This phase is likely due to the 
hydrolysis of GDL into gluconic acid.  The acidification of the environment shifts the 
equilibrium of the carbonate-bicarbonate-CO2 reaction, and eventually settles at a 
specific pH.  Difference in end pH can theoretically only be due to species leaving the 
system, as the amount of GDL and CaCO3 in the system is controlled and should always 
reach the same pH equilibrium value.  The only species able to leave the system is CO2 
in gas form, and so production of CO2 in some systems could be the cause of different 
equilibrium pH values. 
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Figure 35: pH evolution of MPAC hydrogels as a function of time.  Separate graphs 
from top to bottom represent gels of different particle concentration (0.5x, 1x, 2x, 
3x) while individual curves represent gels of different numbers of polyelectrolyte 
bilayers (5, 10, 15, 20, 25, 30 BL). 
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Figure 35: Continued. 
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4.2.3 Composite swelling 
Swelling of the gelled MPAC hydrogels is an important property to understand 
both for in vitro and in vivo applications.  This is particularly true for sensors, where 
differences in distance between pores could drastically impact sensor response.  To 
determine the extent of swelling for different MPAC formulations, gravimetric analysis 
of gelled and swollen hydrogels was performed. 
MPAC gel swelling displayed a strong dependence on concentration (Figure 36).  
Generally, gels made with fewer particles resulted in a higher degree of swelling.  This is 
expected, as gels made with fewer particles should have fewer crosslinks to hold the 
alginate chains together.  At a concentration of 2x and above however, additional 
calcium did not result in a change in swelling, as 2x and 3x gels did not swell above their 
initial weight when exposed to DI water. 
 
Figure 36: Swelling ratio of MPAC gels of different particle concentrations and 
numbers of polyelectrolyte bilayers.  Error bars represent 95% confidence 
intervals (n=5). 
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The behavior observed for these gels (increasing elastic behavior and decreased 
swelling) agrees well with other observations of polymer systems with increasing 
amount of crosslinks.182  In the case of MPAC, it seems that swelling ratio is mostly 
dependent on this attribute of the network.  However, since swelling ratio was defined as 
the ratio of swollen weight to weight after gelation, the swelling ratio does not indicate 
density of the material. 
When we look at the actual weights of the gelled material for a given punch size 
(2.5mm), we see that there is a dependence on bilayer number (Figure 37).  In most 
cases, increasing numbers of bilayers results in increased punch weight and swell 
weight, but these effects cancel each other out when viewed as a swelling ratio.  This 
also occurs predominantly in 0.5x and 1x gels.  Based upon these data, we can say that 
polyelectrolyte bilayers do indeed affect the physical structure of the hydrogel as it 
relates to solvent interactions, even if the overall swelling ratio is not affected. 
 
 
Figure 37: Left: Original (gelled) weight of 2.5mm diameter biopsy punches of 
MPAC hydrogels of different fabrication parameters.  Right: Swelled weight of the 
same hydrogel punches. Error bars represent 95% confidence intervals (n=5). 
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4.2.4 DMA of solvent-exposed gels 
While swelling behavior can give some indications of polymer physical structure, 
it can only give information on a base state versus an equilibrium state.  It does not give 
us information on any changes in physical properties during the transition to equilibrium.  
For many hydrogel systems, it is only important to understand the equilibrium properties 
of the gels, as they will only be used in this state.  In the case of an injectable, in situ-
forming gel such as MPAC, it is very important to understand this interaction, as the gels 
will equilibrate in the environment the gel resides. 
Dynamic mechanical analysis of MPAC gels gives a glimpse of the changes 
occurring within the hydrogels after exposure to DI H2O.  Figure 38 illustrates the 
general stiffening behavior (based upon the ratio of modulus to initial modulus 
(E’(t)/E’i)) exhibited by gels of a particular concentration of particles. 
 
 
Figure 38: Representative MPAC swelling behavior shown as transient changes in 
Ef/Ei over time based upon particle concentration. 
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Here, in gels fabricated with a various particle concentrations, we see two 
different effects on different time scales.  The first is a fast effect, which is dominant in 
gels with higher numbers of particles.  In gels of lower particle concentration, a second 
slower effect dominates the equilibrium transition.  At 1x concentration, gels exhibit an 
equilibrium transition where the two transient effects occur on separate time scales, and 
so are easily visible.  These effects likely represent two important physical phenomena: 
diffusion-based solvent sorption and polymer chain relaxation.  Sorption involves the 
movement and organization of solvent molecules in and around the polymer chains.  
This is a relatively fast effect, which is dependent on the diffusion of solvent through the 
hydrogel.190, 191  The resulting flux of solvent molecules into the hydrogel results in 
initial swelling, and hence stiffening of the hydrogel.  This effect is evident in all 
formulations of MPAC, but its relative impact on mechanical properties depends greatly 
on particle concentration. 
The second effect, which is on a much longer timescale, most likely represents 
polymer chain reorganization.  This involves the physical movement of polymer chains 
and solvent molecules within the hydrogel into a more energetically stable state.192-194  
This effect generally takes longer than solvation, as there are numerous intermediate 
pseudo-stable states in which the polymer can adopt.193  This reorganization is dependent 
on the strength of the solvent interaction with the polymer chains and the relative 
conformational freedom of the polymer backbone and side chains.194  In MPAC 
hydrogels with lower numbers of crosslinks, such as the 1x and 0.5x concentrations, 
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polymer chains will have more conformational freedom, and so theoretically will be able 
to reorganize more extensively. 
These complex equilibrium transitions were quantified with two different 
descriptive values: Ef/Ei and τ. Ef/Ei represents the ratio of equilibrium modulus (Ef) to 
initial modulus (Ei).  τ is a time constant representative of the time it takes for the gel to 
reach equilibrium state from initial state, and includes contributions from both τsolvation 
and τreorganization.  Figure 39 depicts the relationship between Ef/Ei and concentration or 
bilayer number utilized in MPAC fabrication. 
 
 
Figure 39: Left: Ef/Ei plotted against MPAC fabrication parameters of particle 
concentration and polyelectrolyte bilayers. Right: 95% confidence intervals as a 
ratio of the mean. 
 
Ef/Ei has a strong dependence on concentration of particles utilized in the MPAC 
formulation.  This is expected from the swelling data, as 0.5x and 1x gels exhibited 
significant swelling, and stiffening behavior is commonly associated with swelling.182  
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There is little dependence on bilayer numbers, which is also consistent with swelling 
behavior described previously. 
In contrast to the stiffening behavior, equilibration times were different over a 
range of both concentrations and bilayer numbers.  Equilibration time constants 
displayed strong dependence on both concentrations of particles and polyelectrolyte 
bilayers utilized in fabrication (Figure 40).  The greatest τ values occurred at 1x particle 
concentrations between 10 and 20BL, with a maximum at 20BL.  Samples in this region 
exhibit multiphasic behavior, as evident from Figure 38. 
 
 
Figure 40: Left: Tau values plotted against MPAC fabrication parameters of 
particle concentration and polyelectrolyte bilayers. Right: 95% confidence intervals 
as a ratio of the mean. 
 
As mentioned before, the time constant τ is a convolution of two different 
processes: solvation and matrix reorganization, each with their own time constants: 
τsolvation and τreorganization.  It is important to note that in all MPACs, both solvation and 
matrix reorganization do occur, and so each sample will have a τsolvation and τreorganization 
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component to its equilibrium time constant.  However, in cases where reorganization is 
infinitely slow, such as in highly crosslinked networks, the matrix reorganization 
component of τ is such that τreorganization → ∞.  Therefore, the convolution of τreorganization 
and τsolvation → τsolvation and τ ≈ τsolvation.  This is evident in gels of 2x and 3x 
concentrations, where τ is short.  In lower crosslink concentrations, as in 0.5x MPAC, 
the τsolvation and τreorganization are on the same timescale, and so appear as a single 
exponential (Figure 41). 
 
 
Figure 41: Representative 0.5x MPAC normalized modulus changes as a function 
of bilayers utilized in fabrication. 
 
However, the most interesting behavior occurs at 1x concentrations at between 
10 and 20 bilayers, where equilibrium time constants are large.  This area represents an 
area in which solvation and matrix reorganization are occurring in different time scales 
(Figure 38, Figure 42).  Here, matrix reorganization is much slower than in 0.5x 
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MPACs, and the contribution from this slow matrix reorganization causes the overall 
equilibration time to be very slow.  
 
 
Figure 42: Representative 1x MPAC normalized modulus changes during solvation. 
 
Overall, while equilibrium moduli ratios (stiffening) of MPAC hydrogels depend 
almost exclusively on concentration of particles utilized in their fabrication, the 
timescale to reach equilibrium is a much more sensitive property.  Both particle 
concentration and bilayer numbers effect this transition time, predominantly at 1x 
concentration and from 10-20 bilayers.  While this work represents the most basic 
solvation-reorganization model (water), it represents a basis for the study of more 
complex equilibration mechanisms involving protein adhesion, ion exchange, and 
degradation. 
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4.3 Conclusions 
The results presented in this section reveal the impact that MPAC fabrication 
parameters have on the mechanical and kinetic properties of the hydrogels.  Both 
particle/pore concentration and bilayers utilized in the composite have different effects 
on the gelation of the material, and hence its end properties.  As such, these parameters 
have a definitive impact on every aspect from gelation kinetics to pH evolution.  Even in 
the case of swelling, where nanofilm number does not seem to affect behavior, close 
examination with dynamic mechanical analysis reveals that nanofilms do indeed have 
influence. 
Knowledge of the parameters that control the properties of MPAC composites is 
a critical step in developing a functional injectable material containing sensing or 
therapeutic elements.  Specific design of the implantable system will rely on the 
knowledge of implant gelation kinetics for handling, mechanical strength for long-term 
residence in tissue, and swelling behavior for prediction of sensor/therapeutic 
response/release behavior.  Additionally, experiments such as the dynamic mechanical 
analysis in water create a basis for the future evaluation of these systems’ degradation 
profiles under in vivo conditions in which other processes such as ion exchange and 
hydrolytic cleavage occur.  
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5. SENSING MPAC HYDROGELS 
 
In order to prove the utility of MPAC hydrogels as sensor matrix materials, 
MPAC hydrogels were fabricated containing oxygen and glucose sensing chemistry.  
Fabrication parameters including numbers of polyelectrolyte-coated CaCO3 particles, 
polyelectrolyte nanofilm architecture, and nanofilm permeability to glucose were varied 
and changes in sensor response characteristics were observed.  After a brief introduction 
to luminescence lifetime sensor theory, the fabrication, testing, and evaluation of sensor 
response of MPAC oxygen and glucose sensors are discussed. 
Oxygen-sensitive phosphors, as explained briefly in the background section, 
report oxygen concentrations in their immediate environment through changes in their 
luminescence properties.  This effect is due to the collisional quenching of the molecule 
by oxygen.  This quenching manifests as a decrease in luminescence intensity and 
lifetime according to the Stern-Volmer equation166: 
(5.1) 
𝜏0
𝜏
=
𝐼0
𝐼
= 1 + 𝐾𝑠𝑣 ∙ [𝑂2] 
According to this relation, luminescence of the dye is dependent on two factors, oxygen 
concentration [O2] and the Stern-Volmer constant KSV.
166  KSV is an empirically-derived 
value and is dependent on the surrounding environment.  It can be broken down into two 
component parts: KSV= kqτ0, with .τ0 representing the native lifetime of the dye when no 
quencher is present and kq representing the bimolecular quenching constant  For a two 
component system such as with a single dye and a single quencher, the diffusion-
controlled bimolecular rate constant k0 is given through the Smoluchowski equation:
166 
 93 
(5.2) 𝑘0 =
4𝜋𝑁
1000
(𝑅𝑓 + 𝑅𝑞)(𝐷𝑓 + 𝐷𝑞) 
In this relation, k0 is dependent on the collision radii of the fluorophore and 
quencher, Rf and Rq respectively and the diffusion coefficients of the two, Df 
(fluorophore) and Dq (quencher).  N represents Avogadro’s number.  k0 can be related to 
the bimolecular quenching constant by 𝑘𝑞 = 𝑓𝑄𝑘0, where fQ is the quenching 
efficiency.166  Through these relationships, we can see that the quenching behavior of a 
dye will be dependent on the relative diffusivities of the dye and quencher, the 
quenching efficiency and the quenching radii of the components.  Since systems using 
the same dye and quencher will have the same quenching radii and quenching efficiency, 
and temperatures will be kept constant for comparison, the main difference between 
different dye encapsulation/immobilization methods will be the diffusivity of the 
components through the matrix.  As a result, KSV must be determined for any new dye 
immobilization material in a sensor so that the sensor lifetime or intensity will accurately 
reflect the true oxygen concentration.  This is accomplished by measuring the lifetime of 
a particular dye at various quencher concentrations within the sensor.  These lifetime 
values can be plotted in the form of equation (5.1), where a linear fit can be applied to 
determine the slope, KSV.  It is important to note that this relation is the ideal case, but in 
reality there can be different populations of dye with different accessibility to quencher, 
which will cause the Stern-Volmer relationship to deviate from linearity. 
Our laboratory’s glucose-sensitive chemistry relies upon oxygen-sensitive 
phosphors in combination with the enzyme glucose oxidase.133, 167, 168, 170, 195-197  Glucose 
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oxidase is a glycoenzyme which catalyzes the reaction of glucose and oxygen in the 
following simplified reaction: 
(5.3)  Glucose + O2
GOx
→ Glucono-δ-lactone +H2O2 
The sensing chemistry works by consuming oxygen when glucose is present, 
which can be measured by evaluating the luminescence properties of the oxygen-
sensitive dye.  As glucose levels increase, the reaction depletes increasing quantities of 
oxygen, causing the phosphor’s intensity and lifetime to increase accordingly.  While the 
mechanism of transduction is straightforward, the tuning of sensor response is a more 
complicated challenge.  The reaction of glucose oxidase is highly dependent on the 
concentration of enzyme as well as the relative concentrations of the substrates glucose 
and oxygen, which are turn are dependent on diffusion from their source (blood vessels 
in vivo).  Thus, the correct balance of substrate flux is required in order for the sensor to 
function at the desired glucose concentration (40-400mg/dL). 
In the past, our lab has utilized polyelectrolyte multilayers, specifically PSS and 
PAH, as a means to control the flux of glucose and oxygen to the sensing chemistry.133  
It has been shown that decreasing the permeability of glucose in relation to oxygen can 
tune the sensor response characteristics of microsphere-based sensor towards extended 
analytical range.133  However, it has not been shown in bulk materials such as an MPAC 
hydrogel. 
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5.1 Theory and methods 
The basic properties of the oxygen and flux-based glucose sensors are dependent 
on the knowledge of the quenching behavior of the oxygen-sensitive phosphor as well as 
the diffusional properties of the diffusion barrier material.  For enzyme-based glucose 
sensing in particular, glucose and oxygen diffusion control is of paramount importance 
to the function.  To ensure an effective measure of glucose concentrations as they 
change, glucose diffusion in the sensor must be slowed in relation to oxygen diffusion so 
that there is an excess of oxygen in the system.  To characterize the MPAC oxygen and 
glucose-sensing materials, quenching behavior and glucose-dependent responses were 
measured for MPAC gels of different fabrication parameters including CaCO3 particle 
concentration and numbers of polyelectrolyte bilayers.  These quenching and response 
characteristics were compared against the diffusional properties of planar nanofilms of 
the same numbers of layers and architectures. 
5.1.1 Materials 
Poly(sodium 4-styrenesulfonate) (PSS, average Mw = 70,000 Da), 
poly(diallyldimethylammonium chloride) (PDADMAC, typical Mw range =  100,000-
200,000Da) , poly(allylamine hydrochloride) (PAH, average Mw = 15,000 Da), 
poly(sodium 4-styrenesulfonate-co-maleic acid) (PSS-co-MA, 1:1 monomer ratio, 
average Mw = 20,000 Da), and alginic acid sodium salt from brown algae (281 cps for a 
2% aqueous solution at 25 °C), were obtained from Sigma and used without further 
purification.  Pd(II) meso-tetra(4-carboxyphenyl)porphine (PdTCPP) was obtained from 
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Frontier Scientific.  Glucose oxidase from Aspergillus niger (GOx, 257 U/mg solid, 
71.1% protein by Lowry, ca. 160 kDa) was obtained from BBI Enzymes 
5.1.2 Material loading 
GOx and PdTCPP loading in CaCO3 microspheres is a critical variable in the 
formulation of oxygen and glucose-sensing MPAC gels.  Loading of each of the sensing 
chemistry components can affect the signal intensity (affected by dye concentration) and 
sensor response and stability (affected by enzyme loading) of the final sensor.  Because 
of the importance and potential utility of using different quantities of enzyme to tune 
sensor response characteristics, CaCO3 microsphere loading efficiency was evaluated. 
Both GOx and PdTCPP were encapsulated within CaCO3 utilizing the 
coprecipitation technique described previously.  Briefly, loaded CaCO3 microspheres 
were prepared by adding 8 mL CaCl2 (0.25 M) to 8 mL Na2CO3 (0.25 M) containing a 
variable amount of GOx (1-32 mg/mL), and/or 200 µL of 10 mM PdTCPP in DMSO.  
GOx concentrations beyond 32 mg/mL were considered impractical due to the quantity 
of enzyme required for their manufacture.  After addition of the CaCl2, the solution was 
stirred vigorously for 30 s, after which time the agitation was removed and the particles 
were allowed to mature under static conditions for 10 min. For particles to be used in 
PSS/PAH coatings, particles were then dropped into a 50mL beaker containing 16mL if 
20 mg/mL PSS in 50 mM Tris pH 8.5 and allowed to stir for 10 minutes.  The 
suspension was centrifuged and the supernatant was removed. The microspheres were 
then rinsed three times with the appropriate buffer prior to further processing. 
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GOx loading into CaCO3 microspheres was evaluated by dissolving a known 
mass of dried particles in 0.1 M GDL in DI water and measuring the absorbance of the 
resulting solution at 370 nm.  Similarly, loaded PdTCPP was quantified by measuring 
the absorbance of dissolved particle solutions at the 523 nm peak absorbance of the 
phosphor. 
5.1.3 LbL fabrication and testing for glucose and oxygen-sensing MPACs 
The electrostatic adsorption of polyelectrolyes on microspheres depends greatly 
on the surface charge of the substrate layer as well as the charge density of the 
polyelectrolyte.  For example: a highly charged surface will attract more charge in the 
oppositely-charged free polyelectrolyte, leading to better adsorption of the free 
polyelectroyte of the surface.  Three LbL pairs were employed to create layers of either 
high charge or layers of low permeability. PDADMAC and PSS are strong 
polyelectrolytes that easily adsorb to weakly charged surfaces, but do not form major 
diffusion barriers.114, 134, 198, 199  Weak/strong polyelectrolyte pairs, such as PAH/ PSS-co-
MA or PAH/PSS, form thicker, less permeable layers that can slow down small 
molecules such as glucose, but have much lower charge density than strong/strong pairs 
and tend to aggregate under low charge conditions.105, 125, 163, 164  In this work, two 
different film architectures were evaluated.  The first architecture tested was PSS/PAH, 
which was chosen due to the high degree characterization of such films, and its low 
glucose permeability.113, 114, 128, 147, 181, 200  The second film, which consisted of 5 bilayers 
of PDADMAC/PSS and additional PAH/PSS-co-MA layers, provides high charge 
density initially which results in better charge reversal, and then utilizes the weak/strong 
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polyelectrolytes to provide a diffusion barrier.  In addition, PAH/PSS-co-MA has the 
potential to be crosslinked, which could further decrease permeability.201  However, this 
particular combination of polyelectrolytes has never before been tested. 
The difference in permeability of the different layers is the central factor in not 
only the gelation of the MPAC matrix, but the flux-based sensor response.  As such, 
evaluation of the glucose diffusion through these films is crucial to understanding the 
tunability of GOx-based MPAC sensors. CaCO3 particles used in sensing MPACs were 
coated in two different LbL architectures described below.   
5.1.3.1 PSS/PAH particles 
After preparation and initial washing, a single batch of GOx and PdTCPP-loaded 
CaCO3 microspheres (all particles from 1 coprecipitation) was dropped into 15 mL of 
stirring 20 mg/mL PAH in 50 mM Tris buffer (pH 8.5) in a 50 mL beaker with a 
triangular stir bar (25 mm).  Particles were allowed to stir for 10 minutes, and then 
collected in a 50 mL tube, washed 3 times in 50 mM Tris buffer (pH 8.5) and 
resuspended in 15 mL 50 mM Tris buffer (pH 8.5).  The particles were then added to 15 
mL of 20 mg/mL PSS and stirred for 10 minutes similar to PAH.  This process was 
repeated until the desired number of layers was deposited.  Charge reversal at each layer 
was determined by zeta potential analysis. 
5.1.3.2 PDADMAC/PSS + PAH/PSS-co-MA 
One batch of particles at a time (all particles from 1 coprecipitation (either GOx 
+ PdTCPP or PdTCPP only) was mixed with 1 mL of 20 mg/mL PDADMAC in 5 mM 
Na2CO3 pH 8.0 in a microcentrifuge tube.  Stability of the initial charged layer was 
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evaluated after washing and over time.  Once acceptably-stable conditions were 
determined, alternating strong polyelectrolytes (1 mL 20 mg/mL PDADMAC/PSS in 5 
mM NaHCO3, pH 8.0, mixed for 0.5 minutes) were deposited and evaluated for surface 
charge by monitoring surface charge after each additional layer.  After the number of 
bilayers required to cause stabilization of surface charge was determined, the 
strong/weak polyelectrolyte combination, PSS-co-MA/PAH was deposited in increasing 
numbers from 5-25 bilayers and evaluated for charge reversal by zeta potential 
measurements.  The PSS-co-MA/PAH layers were deposited in the following fashion: 1 
mL (20 mg/mL PAH in 5 mM NaHCO3 pH 8.0) was added to the particles and mixed 
for 0.5 minutes.  The particles were then centrifuged down at 500 g and washed once 
with 1mL 5mM NaHCO3 pH 7.2.  After removal of the wash solution by centrifugation 
at 500g, 1 mL (20mg/mL PSS-co-MA in 5mM NaHCO3 pH 7.2) was added to the 
particles, mixed for 0.5 minutes, and washed with 5mM NaHCO3 pH 8.0 in a similar 
fashion.  This process was repeated until the desired number of layers was achieved. 
5.1.3.3 Layer-by-layer diffusion analysis 
Diffusion of glucose through the polyelectrolyte multilayers was evaluated to 
determine the permeability of the layers to glucose.  Polyelectrolyte multilayers were 
deposited by planar LbL technique in which polyelectrolytes are deposited on a porous, 
planar surface in alternating fashion.  Varying numbers of polyelectrolyte multilayers 
were deposited on porous alumina disks (Anodisc 25, 60 μm thick, 0.02 μm pore 
diameter) under the same conditions as used for CaCO3 particles of each LbL 
architecture.  The LbL-coated disks were placed in PermeGear Side-bi-Side diffusion 
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cells.  Disks were placed between feed reservoirs containing 100 mg/dL glucose and 
permeate reservoirs with buffer only.  Samples were kept at room temperature and under 
constant stirring.  Aliquots of solution were taken from both feed and permeate 
reservoirs at designated intervals of time and analyzed for glucose content using a YSI 
2700 Biochemistry Analyzer.  Change in concentration over time (dC/dt) of the 
permeate side was analyzed for films of different architectures (PDADMAC/PSS + 
PAH/PSS-co-MA and PAH/PSS) and number of polyelectrolyte bilayers (0-30 BL). 
5.1.4 Oxygen-sensing MPAC 
Oxygen-sensitivity of MPAC gel formulations has implications for the material’s 
use in vivo oxygen sensing.  Additionally, the performance of glucose-sensing MPACs 
will be dependent on the behavior of the oxygen-sensitive phosphors contained within.  
As MPAC-based oxygen or glucose sensors have never before been tested, their oxygen-
dependent behavior was evaluated.  Oxygen-sensing MPAC gels were evaluated for 
oxygen sensitivity using a custom flow-through and time-domain lifetime analysis 
system. 
5.1.4.1 Sensor formulations 
CaCO3 particles used for oxygen-sensing MPAC contained only PdTCPP (no 
GOx). These PdTCPP-loaded CaCO3 microspheres were coated with PDADMAC/PSS + 
PAH/PSS-co-MA nanofilm architecture.  MPAC gels were fabricated with a 3x 
concentration of CaCO3 microspheres of different numbers of bilayers (5, 10, 15, 20, 25, 
30).  Gels were cast between glass slides with 0.06” Teflon spacers.  Biopsy punches 
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(2.5 mm) of samples were taken from the larger slab and were tested for oxygen 
sensitivity using a custom flow-through system (Figure 43). 
 
 
Figure 43: Schematic of the flow-through system utilized for glucose and oxygen-
sensing MPAC sensors.  Buffer flow during oxygen experiments (recirculating flow) 
is represented by green arrows.  Buffer/analyte flow during glucose experiments is 
represented in blue. 
 
5.1.4.2 Data collection and analysis 
Sensor punches were placed in a custom flow-through cell three at a time (Figure 
44).  Buffer solution (10mM Tris pH 7.4) was flowed over the surface of the sensors and 
recirculated from a reservoir.  Solution oxygen was controlled by bubbling a mixture of 
oxygen and nitrogen gases within the buffer reservoir.  Oxygen/nitrogen mix ratios were 
controlled via mass flow controllers and solution oxygen concentration was monitored 
with an oxygen electrode (Unisense Ox500) to confirm changes in dissolved oxygen 
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within the reservoir.  For 0% oxygen, a solution of extreme excess GOx (1 mg/mL) and 
glucose (30% wt/wt) in buffer was placed in the flow-cell and allowed to react until 
oxygen was eliminated from the system. Sensors within the flow cell were interrogated 
from below via a fiber bundle attached to a custom time-domain lifetime system (Figure 
44). 
 
 
Figure 44: Schematic of the flow cell.  Buffer containing varying levels of glucose or 
oxygen is flowed over the surface of the sensor, which is interrogated from below by 
a fiber bundle. 170 © 2011 IEEE 
 
At each oxygen concentration, ~100 data points from each sensor in the flow cell 
were collected and averaged to determine the oxygen/lifetime relationship of that sensor.  
Oxygen concentrations were calculated by utilizing the partial pressure of the oxygen at 
a particular gas, assuming saturation from bubbling, and correcting this value for salinity 
and temperature using an oxygen solubility table provided by Unisense (salinity =1.3, 
temperature = 37C).  Inverted measured lifetime values were plotted against oxygen 
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concentration in the form of equation (5.1).  Each plotted sensor response was then fit 
linearly using a least-squares regression forced through a y-intercept of 1 in MatLab to 
determine its Stern-Volmer constant (KSV).  KSV for a particular sample type was 
produced from an average of KSV values from different samples of the same type.  
5.1.5 Glucose-sensing MPAC 
Glucose-sensing MPACs were fabricated from CaCO3 particles loaded with GOx 
and PdTCPP.  As glucose-sensing MPACs have never before been evaluated, the most 
important tunable parameters, particle concentration and bilayer number (representing 
permeability), were varied and evaluated for sensor response characteristics. 
5.1.5.1 Sensor formulations 
Two separate nanofilm architectures were used in the fabrication of glucose-
sensing MPACs: PAH/PSS (described in 5.1.3.2) and PDADMAC/PSS + PAH/PSS 
(described in 5.1.3.3).  In all glucose-sensing MPACs, CaCO3 particles utilized were 
coprecipitated with 8 mg/mL GOx and 200 µL 10 mM PdTCPP in DMSO (refer to 
loading section). 
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For PAH/PSS architecture, MPAC gels were fabricated with varying 
concentrations of CaCO3 microspheres (1, 2, 3, 4, 5x) of different numbers of bilayers 
(5, 10, 15, 20, 25, 30).  Gels were cast between glass slides with 0.06” Teflon spacers.  
Biopsy punches (2.5 mm) of samples were taken from the larger slab and were tested for 
glucose sensitivity using a custom flow-through system (Figure 43).  For 
PDADMAC/PSS + PAH/PSS architecture, 2x and 3x MPAC gels were evaluated from 
10-30 BL. 
5.1.5.2 In vitro testing apparatus and instrumentation 
Individual MPAC samples were immobilized in a custom flow-through cell 
(Figure 44).  An air-equilibrated buffer solution (10 mM Tris pH 7.4) containing 
different concentrations of glucose within the physiologic range (40-400mg/dL) was 
flowed over the surface of the sensor.  Sensor sample phosphorescence was captured 
from below via a fiber optic bundle connected to a custom time-domain lifetime system 
(as in oxygen-sensing MPACs). 
5.1.5.3 Data collection and analysis 
Sensor lifetime values were recorded via a custom LabView program in a 
continuous fashion, resulting in a “stair step” response (Figure 45, top).  Mean values at 
steady state lifetimes at each glucose concentration were used to create response curves 
(Figure 45, bottom). 
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Figure 45: Top: Sample “stair-step” raw response data. Bottom: Resulting glucose 
response curve calculated from the average raw data steady-state values at each 
concentration.  Increasing levels of glucose cause increased lifetime of the 
phosphor. 
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Important figures of merit calculated for each sensor formulation were limit of 
detection (LOD), representing the lowest detectable glucose concentration, analytical 
range, representing the glucose concentrations that can be accurately determined from 
sensor lifetime values given the variability of sensor signals, and sensitivity, representing 
the change in signal level over the analytical range.  LOD was defined as the glucose 
concentration at which the corresponding lifetime value is three standard deviations 
above the measured baseline lifetimes (variability at 0 mg/dL glucose).  The maximum 
differentiable glucose value (MDGV, at the top of the analytical range) was similarly 
defined as the glucose concentration at which the corresponding lifetime value is three 
standard deviations of the maximum measured lifetimes below the fitted maximum 
lifetime.  Analytical range was defined as the difference between the MDGV and the 
LOD.  Sensitivity was determined by taking the percent difference between fitted 
lifetime values at MDGV and LOD and dividing this value by the analytical range.  
Lastly, response time was calculated by utilizing the first transition in concentration (0 to 
25 mg/dL glucose).  This initial transition was chosen as a means to compare different 
samples as the calculation of response time is inaccurate when samples begin to saturate 
(there is little or no change in lifetime between concentrations) and this transition is 
before the saturation point in all samples.  The transition is determined to begin when the 
measured lifetime value exceeds three times the standard deviation of the baseline and 
ends when the lifetime value approaches three standard deviations of the next 
concentration’s mean lifetime value.  The time of the transition from start to end points 
is given as the initial response time. 
 107 
5.2 Results and discussion 
5.2.1 GOx and PdTCPP loading 
Utilizing the GOx-specific absorbance at 370 nm and the PdTCPP-specific 
absorbance at 523 nm, the loading of each was determined.  In all particles containing 
PdTCPP, the same 200 µL 10 mM solution in DMSO was used as this amount resulted 
in sufficient phosphorescence intensity.  PdTCPP loading efficiency into CaCO3 
particles was found to be 27 ± 9%, which corresponds to estimated concentration within 
a particle of 70 ±30 µM and an estimated mass dye /mass particle ratio of 1.1 ± 0.5 x 10-
3.  GOx-loaded particles showed a concentration-dependent loading (Figure 46).  As 
GOx concentrations in the coprecipitation solution increased, loading quantity increased 
in a linear fashion over the concentrations tested.  It is important to note that the 
morphology of particles changed dramatically from lower concentrations of GOx to 
higher concentrations of GOx (Figure 46).  Particles became significantly smaller and 
less uniform as more GOx was used in their manufacture.  A concentration of 8 mg/mL 
GOx was chosen for subsequent glucose-sensing MPAC testing due to the lack of 
morphological uniformity and impractical quantities of enzyme required beyond that 
concentration. 
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Figure 46: Top: Ratio of weight of GOx loaded per total weight of loaded CaCO3 
microspheres. Bottom: Morphological differences in CaCO3 spheres with low levels 
of GOx (4 mg/mL GOx, left) and at high levels (32 mg/mL GOx, right). Error bars 
represent 95% confidence intervals (n=3). 
 
5.2.2 LbL stability and permeability 
5.2.2.1 LbL deposition on CaCO3 
Layer-by-layer on CaCO3 particles containing GOx and PdTCPP resulted in 
charge reversal for both LbL architectures (Figure 47).  However, in the case where 
strong polyelectrolytes were not utilized from the start, full charge reversal did not occur 
until about 5 bilayers.  While this may seem to indicate that layers are not forming, this 
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is actually the result of measuring the zeta potential in excess of several hours after 
deposition.  It was observed that there is a time-dependent loss of charge at lower 
polyelectrolyte numbers (Figure 48).  This effect has been observed by others in the case 
of nanoparticle CaCO3 coated in alginate polyelectrolyte.
202  Addition of polyelectrolyte 
to the coprecipitation solution has been shown to increase stability of the particles,135 but 
utilizing polyelectrolyte in the coprecipitation results in extremely low protein loading.  
This is an important observation for the construction of polyelectrolyte multilayers on 
CaCO3 microspheres not utilizing a polyelectrolyte in the coprecipitation solution.  
Additional polyelectrolyte layers must be deposited within a reasonable time of the 
deposition of the previous layer.  Therefore, depositions applied in this work were 
conducted in rapid succession. Specifically, after assembly of a single layer, washes 
were completed and subsequent layers were deposited within 5 minutes of one another.  
Particles with below 5 bilayers of material were never left in polyelectrolyte-free 
solutions for extended periods of time.  In addition to deposition times, zeta potential 
measurements of these layers must be made quickly in order to ensure an accurate 
surface charge measurement.  This is especially important when comparing layers of 
different materials with different charge density, as these layers could display 
differences in zeta potential simply as a result of when they were measured. 
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Figure 47: Top: Zeta potential of loaded CaCO3 particles coated in PAH/PSS 
nanofilm architecture as a function of bilayer number.  Bottom: Zeta potential of 
loaded CaCO3 particles coated in PDADMAC/PSS + PAH/PSS-co-MA nanofilm 
architecture.  Error bars represent 95% confidence intervals (n=3) 
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Figure 48: Stability of a single layer of PDADMAC on loaded CaCO3 particles as a 
function of time since deposition and buffer type. 
 
5.2.2.2 LbL permeability 
Glucose permeabilities of the two nanofilm architectures utilized in glucose-
sensing MPAC hydrogels were evaluated using PEMs deposited on planar porous 
substrates.  Films were prepared with identical deposition conditions used to create 
capsules in an effort to closely match the film architecture and porosity.  Average rates 
of change in concentration (dC/dt) of the permeate reservoirs were calculated by finding 
the slope of glucose concentration over time and averaged between three independent 
samples.  Figure 49 shows the dC/dt values for both films and the bare substrate.  The 
data indicate that, as expected, the strong/strong polyelectrolytes PDADMAC/PSS slow 
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differences in thickness and porosity.203  Layers of PAH/PSS deposited under the 
described conditions cause a drastic change in permeability with only the first 5 bilayers.  
Subsequent layers showed decreased permeability, but at a decreasing rate.  Overall, 
PAH/PSS films were significantly less permeable than PDADMAC/PSS + PAH/PSS-co-
MA films of similar numbers of layers.  This difference could be due to two different 
factors: 1) the deposition pH of PAH, which has been shown to affect the thickness of 
layers of weak polyelectrolytes,199 or 2) the use of PSS versus PSS-co-MA.  While the 
differences in film properties due to deposition pH is a known relationship, structural 
differences in layers of PSS versus PSS-co-MA deposited in various conditions have not 
been fully characterized.  Therefore, it is indeterminate how these two factors together 
may cause the observed differences.  These observations are significant, as choosing the 
appropriate film architecture and therefore permeability is particularly important for 
flux-based microparticle glucose sensors, which have been shown to have drastically 
different response characteristics based upon film diffusion properties.133  
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Figure 49: Change in concentration of glucose on the permeate side of the diffusion 
apparatus as a function of numbers of polyelectrolyte bilayers and architecture 
type. Error bars represent 95% confidence intervals (n=3). 
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interaction.166  In the case of MPAC hydrogels, phosphor and oxygen are expected to be 
freely mobile within the polyelectrolyte pores (as nanoparticles were shown to be free 
moving),7 and so polyelectrolyte multilayers were not expected to cause major 
differences in quenching behavior. 
Oxygen-sensitive MPAC gels with different numbers of polyelectrolyte bilayers 
displayed a characteristic dependence on oxygen concentration.  As oxygen 
concentration decreases, lifetime of the phosphor contained within the micropores of the 
MPAC increases with increasing sensitivity (Figure 50).  When transformed into the 
relation 
𝜏0
𝜏
 the values exhibit a non-linear dependence on oxygen (Figure 51).  This 
behavior has been observed for PdTCPP in certain polymer matrices and a two-site 
Stern-Volmer relationship better approximates the dye’s interaction with oxygen in this 
case.204 
 
 
Figure 50: Average lifetime values of oxygen-sensitive 3x MPAC gels with varying 
numbers of polyelectrolyte bilayers.  Error bars indicate standard deviations (n=3). 
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Figure 51: τ0/τ relationship of 3x MPAC gels fabricated with different numbers of 
polyelectrolyte bilayers. 
 
In this situation, the simple linear (one-site) Stern-Volmer model does not 
describe the quenching behavior of the dye. Instead, a multi-site equation is a better fit.  
Two-site Stern-Volmer relations have three components, the two Stern-Volmer constants 
representing the two different dye-quencher interactions (KSV1, KSV2) and the fraction of 
dye molecules in the first state ( f ). This relationship is given in the form: 
(5.4)  
𝜏0
𝜏
= [
𝑓
1+𝐾𝑠𝑣1∙[𝑂2]
+
1−𝑓
1+𝐾𝑠𝑣2∙[𝑂2]
]
−1
 
Fitting the MPAC oxygen sensing data to this equation using NLLS gives the parameters 
in Table 2. 
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Table 2: Two site Stern-Volmer parameters for oxygen-sensitive MPAC gels of 
different numbers of polyelectrolyte bilayers.  Values are averages of different 
samples with 95% confidence (n=3). 
Bilayer Number 
KSV1 (µM-1) 
(n=3, α=0.05) 
KSV2 (µM-1) 
(n=3, α=0.05) 
f 
(n=3, α=0.05) 
5 0.12 ± 0.0087 1.41 ± 1.55 x 10-3 0.87 ± 0.018 
10 0.15 ± 0.019 3.12 ± 1.37  x 10-3 0.84 ± 0.015 
15 0.13 ± 0.038 2.42 ± 1.33 x 10-3 0.86 ± 0.046 
20 0.15 ± 0.025 6.81 ± 1.24 x 10-14 0.81 ± 0.013 
25 0.12 ± 0.015 9.40  ± 1.34 x 10-14 0.84 ± 0.018 
30 0.11 ± 0.019 2.31  ± 0.098 x 10-14 0.88 ± 0.011 
 
 
Though are some significant differences between sample types, namely the KSV1 
of 30BL samples and the f value of 20 BL samples are lower than all other samples and 
the f value of 30 BL is slightly lower than 10BL.  Overall, KSV1 and f values for different 
MPAC types do not follow a strong trend and do not differ greatly in magnitude.  
However, KSV2 values do significantly differ with MPAC gels made with 20 bilayers or 
more.  The orders of magnitude difference in KSV1 and KSV2 in these samples 
corresponds to the marked nonlinearity observed (Figure 51).  This difference in site 
interaction causes these sensors to be much less sensitive to oxygen at higher 
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concentrations, while having relatively similar sensitivity at lower oxygen 
concentrations.  The most likely cause for this effect is the presence of a population of 
unquenchable phosphor, which continues to emit at higher oxygen concentrations.  This 
population is likely precipitated dye within the capsules, as the phosphors have limited 
solubility in water.  However, according to the data, the population fraction of the 
precipitated dye ( f ) is very similar for all samples.  This means that the accessibility of 
the dye, represented by KSV2, is primary cause for this difference.  This major difference 
could be due to organization of the dye precipitates, such as size, surface area or other 
complexation effects.  The precipitation of dye, and hence the precipitate size and 
morphology, could be affected by the speed of dissolution of the CaCO3 templates or the 
pH of the solution during dissolution, both of which are dependent on bilayer numbers. 
Regardless of the mechanism, having this unquenched population results in a lower 
overall sensitivity of the MPAC sensors for the entire range of oxygen concentrations.  
However, it does increase the relative baseline lifetime and intensity, which could be 
advantageous for in vivo measurement where any increase in signal intensity would be 
beneficial.  Additionally, the most relevant oxygen concentrations for in vivo oxygen 
sensing lie below 100 µM, where all MPAC sensors have very high sensitivity. 
5.2.4 Glucose-sensing MPAC 
Glucose-sensing MPACs were fabricated with particles containing the enzyme 
GOx and the oxygen sensitive porphyrin PdTCPP.  Sensors fabricated with two different 
nanofilm architectures (PAH/PSS and PDADMAC/PSS + PAH/PSS-co-MA), different 
microsphere concentrations (1x-5x) representing gel porosity and overall enzyme 
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concentration, and numbers of polyelectrolyte bilayers (5-30BL) representing different 
permeabilities were evaluated for sensor response by exposing punches of each material 
to glucose in the physiologic range (40-400 mg/dL) and monitoring the phosphorescence 
lifetime of the dye within the MPACs.  Representative raw data from these experiments 
are given in Figure 45 (above).  Glucose-sensing MPAC hydrogels were expected to 
have response characteristics that are dependent on bilayer number while not being 
dependent on porosity.  With greater diffusion barrier to glucose, it was expected that 
sensitivities would decrease and analytical ranges to increase, as this relationship has 
been previously explored in systems consisting of polyelectrolyte-coated microspheres, 
which resemble the pores in the MPAC.133 
MPAC gels constructed with PAH/PSS nanofilm architectures showed a glucose 
response dependence on both concentrations of microspheres as well as numbers of 
polyelectrolyte bilayers utilized in fabrication.  There was a clear trend for MPACs 
fabricated with increasing concentrations of particles towards higher sensitivity and 
lower analytical range (Figure 52).  The observed differences in responses represent the 
classic inverse relationship between sensitivity and analytical range in flux-based 
sensors, and can be seen quantitatively in Table 3.  For maximum utility in vivo, the 
analytical range of glucose sensors must extend from low glucose < 40 mg/dL to up to 
400 mg/dL, although the most important analysis region is the hypoglycemic region.  
Gels with the highest concentrations of particles saturated at near 50 mg/dL glucose and 
had an over 600% total change in lifetime while gels fabricated with the lowest 
concentration of particles had a nearly undetectable change in response over the range of 
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glucose concentrations.  Gels with 2x and 3x particle concentrations maintain high 
sensitivity (~0.5% per mg/dL glucose) while having reasonable analytical ranges (~240 
mg/dL glucose).  In addition, gels of different concentrations displayed some small 
differences in initial response times.  Gels with larger concentrations of particles had 
slightly longer initial response times, indicating a possible difference in bulk transport in 
the hydrogel.  This effect would likely be due to the increase in calcium utilized in these 
gels, as higher crosslinker concentrations result in changes in mechanical properties as 
evidenced in Section 4.  These changes could influence the transport through the alginate 
itself.  It is important to note as well that in the calculation of response time, increases in 
variability in steady state lifetime measurements could cause decreases in calculated 
response times in these samples.  Even so, in all cases, gels had response times lower 
than ten minutes, which is on the order of the delay in time between changes in blood 
and interstitial glucose in vivo, and so would allow for the accurate determination of 
changes in glucose.205, 206   
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Figure 52: Response curves of 30BL MPAC gels made with different concentrations 
of particles (1-5x).  Top: Lifetime versus glucose concentration. Bottom: Percent 
change versus glucose concentration. Error bars indicate standard deviations 
(n=5). 
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Table 3: Sensor figures of merit for MPAC sensors fabricated with different 
concentrations of CaCO3 microspheres.  Values represent averages of individual 
sensor responses with 95% confidence (n=5). *Values that could not be accurately 
calculated based on the formula utilized. 
 
Concentration 
(30BL) 
Enzyme 
Concentration 
(mg/mL 
MPAC) 
Sensitivity 
(% per  
mg/dL 
glucose) 
LOD 
(mg/dL 
glucose) 
Analytical 
Range  
(mg/dL 
glucose) 
Initial 
Response 
Times (min) 
1 0.4 ± 0.4 x 10-2 0.3 ± 0.04 34.2 ± 13.7 
34.2 – 85.7 
(51.5) 
* 
2 0.9 ± 0.7 x 10-2 0.4 ± 0.10 6.1 ± 1.6 
6.1 – 237.8 
(231.7) 
5.0 ± 1.8 
3 1.3 ± 1.1 x 10-2 0.8 ± 0.2 4.4 ± 1.8 
4.4 – 246.1 
(241.6) 
6.5 ± 1.5 
4 1.7 ± 1.5 x 10-2 2.3 ± 0.7 1.9 ± 0.3 
1.9 – 111.0 
(109.1) 
8.7 ± 1.1 
5 2.2 ± 1.8 x 10-2 7.2 ± 2.4 0.2  ± 0.03 
0.2 – 64.3 
(64.2) 
8.1 ± 0.3 
 
 
In an ideal case, where oxygen and glucose are supplied equally to identical 
individual pores, the pores will behave independently, and oxygen levels within the 
pores should not be affected by total porosity.207  However, if pores are close enough to 
cause depletion of oxygen near surrounding pores, the pores will behave in a cooperative 
manner, where pores begin to affect each other’s responses.  In this case, the sensor 
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response of the entire matrix will be affected.207  This seems to be the case in MPACs 
made with higher particle concentrations, where oxygen depletion (measured by 
luminescence lifetime) is much higher.  In lower particle concentrations, increasing 
availability of oxygen as a result of higher oxygen concentrations around the pores 
lowers the observed lifetimes while extending the range of the sensors.  This means that 
increasing quantities of glucose are required to deplete the larger quantities of oxygen 
available.  Additionally, once the concentration of particles is low (1x), there is not 
enough enzyme present (Table 3) to significantly deplete oxygen within the pores, 
despite having large quantities of glucose.  This results in the observed lowering of 
maximum response as particle (and hence enzyme) concentration decreases.208  From 
these observations, we can conclude two things: 1) pores interact with one another in a 
cooperative manner (at least at high concentrations) and 2) the concentrations of GOx in 
combination with the number of bilayers utilized in this study do not provide an 
appropriate reaction/diffusion balance to allow for depletion of oxygen at low pore 
concentrations. 
Based upon the favorable figures of merit of MPAC gels fabricated at a particle 
concentration of 3x, this concentration was chosen to hold constant for comparing 
MPAC sensor glucose response as a function of bilayer numbers (Figure 53). 
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Figure 53: Response curves of 3x MPAC gels made with different numbers of 
polyelectrolyte bilayers.  Values are given as percent change versus glucose 
concentration. Error bars represent standard deviations (n=5). 
 
At 3x concentration of particles, glucose-sensing MPAC gels displayed a 
significant dependence on numbers of bilayers for all figures of merit except for initial 
response times.  The initial response times of MPAC samples fabricated with different 
bilayer numbers showed no apparent trend, and all remained at or below ~10 minutes.  
Gels fabricated with lower numbers of layers generally exhibited higher sensitivity and 
lower analytical ranges (Table 4).  This behavior resembles a similar effect seen with 
previous microsphere-based sensors developed in our lab.133 
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Table 4: Sensor figures of merit for MPAC sensors fabricated with different 
numbers of polyelectrolyte bilayers.  Values represent averages of individual sensor 
responses with 95% confidence (n=5). 
 
Bilayer Number 
(3x) 
Sensitivity 
(% per mg/dL 
glucose) 
LOD 
(mg/dL glucose) 
Analytical Range 
(mg/dL glucose) 
Initial Response 
Time (min) 
5 
6.5 ± 0.5 0.6 ± 0.2 0.6 – 65.1 (64.5) 8.5 ± 1.4 
10 
3.8 ± 0.9 1.6 ± 0.3 1.6 – 85.0 (83.4) 9.7 ± 1.0 
15 
3.9 ± 0.5 2.6 ± 0.6 2.6 – 87.5 (84.9) 8.2 ± 0.7 
20 
6.6 ± 0.8 0.4 ± 0.2 0.4 – 58.4 (58.0) 9.7 ± 0.7 
25 
4.8 ± 1.0 1.5  ± 0.2 1.5 – 78.7 (77.2) 10.3 ± 0.5 
30 
0.8 ± 0.2 4.4 ± 1.8 4.4 – 246.1 (241.6) 6.5 ± 1.5 
 
 
When comparing diffusion of glucose through planar LbL with the sensitivities 
and ranges obtained from sensors fabricated with this LbL architecture (Figure 54), a 
clear relationship between diffusion behavior and response characteristics is evident 
(Figure 54).  Generally, as glucose flux through the nanofilm increases, sensitivity 
increases and analytical range decreases.  This follows a similar trend as what was 
observed with organo-silicate and alginate microspheres in the past,133 and would seem 
to indicate that increasing film diffusion barriers are lowering the ratio of glucose and 
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oxygen flux (JG/JO), resulting in depletion of oxygen to occur over a wider range of 
glucose.  However, based upon data collected from MPACs fabricated with different 
concentrations of particles we must also consider differences in cooperative effects, such 
as the distance between particles, the degree of oxygen depletion between particles, and 
the relative diffusion of glucose and oxygen through the alginate matrix.  Based upon the 
data gathered, it can be concluded that there is indeed a relationship between nanofilm 
layer number (i.e. permeability) and sensitivity and range.  Unfortunately, due to the 
presence of cooperative effects, comparisons to nanofilm-sensor response dependencies 
in the previously described one dimensional models of organo-silicate and alginate 
microspheres209 are not appropriate based on the complexity of the MPAC system. 
 
 
Figure 54: Sensitivity (x, blue) and analytical range (+, red) plotted against dC/dt 
values based upon numbers of polyelectrolyte bilayers.  Fits are shown in dotted 
lines for sensitivity (blue) and analytical range (red). 
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Based upon favorable response parameters found using 2x and 3x PAH/PSS 
nanofilm architecture, PDADMAC/PSS + PAH/PSS-co-MA-based MPAC gels with 
varying numbers of bilayers (0-30BL) were fabricated and tested at 2x and 3x 
concentrations.  At the 2x concentration, response characteristics of the MPAC gels had 
similar trends to the materials made with PAH/PSS, with decreasing sensitivity and 
increasing linearity with increasing numbers of bilayers (Figure 55).  However, 
analytical ranges for high numbers of bilayers were impossible to determine, as the 
signal change from 0 to 400 mg/dL glucose was within baseline error (Table 5).  In 
addition, this baseline variability prevented the accurate calculation of initial response 
times for these samples.  With 3x concentration of particles, no clear trend in sensitivity 
based upon bilayer number was determined.  However, analytical range trending was 
consistent for these samples.  Overall, MPAC samples with this nanofilm architecture 
did not seem to be as dependent on bilayer numbers as in the case of PAH/PSS 
architecture, and did not have response characteristics proportional to measured 
difference in dC/dt. 
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Figure 55: Response curves of 2x (top) and 3x (bottom) MPAC gels made with 
different numbers of polyelectrolyte bilayers.  Values are given as percent change 
versus glucose concentration.  Error bars represent standard deviations (n=3). 
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Table 5: Sensor figures of merit for MPAC sensors fabricated with different 
numbers of polyelectrolyte bilayers.  Values represent averages of individual sensor 
responses with 95% confidence (n=5).  aSensors fabricated at 2x concentration. 
bSensors fabricated at 3x concentration.  *Values that could not be accurately 
calculated based on the formula utilized. 
 
Bilayer 
Number 
Sensitivity 
(%) 
LOD 
(mg/dL 
glucose) 
Analytical Range 
(mg/dL glucose) 
Initial 
Response 
Time (min) 
10 
2.6 ± 0.9 a 
0.9 ± 0.3b 
9.3 ± 1.0a 
8.1 ± 3.5b 
9.3 – 221a (211) 
8.1 – 474 (465)b 
2.8 ± 1.0a 
3.0 ± 1.5b 
15 
0.5 ± 0.2a 
0.2 ± 0.1b 
23.4 ± 8.3a 
26.5 ± 6.9b 
23.4 – 371 (348)a 
26.5 – 3.4 x 103 (3.3 x 103)b 
* 
* 
20 
0.6 ± 0.4a 
0.2 ± 0.1b 
24.6 ± 7.6a 
35.1 ± 18.0b 
24.6 – 510 (485)a 
24.6 - 724 (689)b 
* 
* 
25 
0.3 ± 0.1a 
0.3 ± 0.1b 
13.7 ± 3.7a 
10.2 ± 3.3b 
13.7 – 477 (464) a 
10.2 – 555 (545)b 
* 
2.1  ± 0.9b 
30 
0.1 ± 1.2 x 
10-2 a 
0.9 ± 0.2b 
62.4 ± 3.7a 
6.1 ± 1.1b 
* 
6.1 – 271 (266)b 
* 
3.2  ± 0.9b 
 
Looking back at dC/dt values for both film architectures, we can see that the 
dC/dt values of PDADMAC/PSS + PAH/PSS-co-MA films were much higher than those 
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for PAH/PSS films.  In fact, the lowest dC/dt value for PDADMAC/PSS + PAH/PSS-
co-MA films was at 30BL, and this value was still greater than dC/dt of PAH/PSS films 
at 20BL.  Looking at Figure 54, we see that the primary region of change in response 
characteristics for PAH/PSS lies below 0.004 g/L•hour.  Even at 30BL, 
PDADMAC/PSS + PAH/PSS-co-MA-based films have significantly higher dC/dt than 
0.004 g/L•hour.  As a result, we would expect that PDADMAC/PSS + PAH/PSS-co-
MA-based MPAC would have less dependence on the film dC/dt.  Additionally, sensor 
response characteristics of MPACs fabricated with PDADMAC/PSS + PAH/PSS-co-
MA displayed overall lower sensitivities than MPACs made with PAH/PSS for similar 
dC/dt.  This seems to indicate the presence of another effect aside from diffusivity 
differences.  Reduced sensitivity, which results from lower oxygen depletion within the 
sensor, could therefore plausibly be the result of increased distances between particles 
(swelling), or reduced enzyme activity.  Due to the very small observed changes in 
swelling behaviors with bilayer numbers at high particle concentrations in Section 4, the 
reduction in sensitivity for a given dC/dt is more likely due to reduced enzyme activity.  
If enzyme is less active in the particles, then there would be less average active enzyme 
per volume of entire MPAC sensor.  Due to the cooperative nature of the pores, this 
would manifest in a similar fashion to PAH/PSS-based MPAC gels fabricated with 
varying particle concentrations as seen in Figure 52; and in fact, this is what is observed.  
As the same CaCO3 particle fabrication technique was utilized for both nanofilm 
architectures, it would be expected that enzyme activities would be similar at that stage.  
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Therefore, the most reasonable point for enzyme activity loss is during the LbL 
deposition. 
5.3 Conclusions 
The work in this section represents the foundation of the sensing application for 
MPAC hydrogels, with a specific focus on oxygen and glucose sensing.  MPAC 
hydrogels were shown to function as matrices for holding oxygen and glucose sensing 
chemistry.  Both phosphor and glucose oxidase can be encapsulated within CaCO3 and 
can be retained within the pores, and interrogated externally using optical techniques.  
MPAC sensors responded to external changes in oxygen or glucose, and are highly 
dependent on fabrication parameters. 
In the case of oxygen-sensitive MPACs, polyelectrolyte bilayers had a minor 
influence on sensor behavior causing increased non-linearity of the Stern-Volmer 
relationship, likely due to the precipitation of dye within the capsules during dissolution 
of the template.  However, oxygen-sensitive MPAC gels all showed extremely high 
sensitivity to oxygen in the physiologically-relevant range (< 100 µM). 
Glucose-sensing MPACs were demonstrated to have tunable sensitivity and 
range depending on the concentration of particles or the numbers of bilayers utilized in 
fabrication.  However, dependence on particle concentration of MPAC gels indicates 
that the individual pores within the alginate matrix are interacting with each other in a 
cooperative way.  If pores were truly independent reactors, the response profiles of 
MPACs made with different numbers of particles would have responses dependent on 
the polyelectrolyte multilayers only.  This would make sensor response characteristics 
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variable for formulations in which mechanical stability is an issue (such as was observed 
in Section 3).  This could explain the lack of clear trends in formulations utilizing 
PDADMAC/PSS + PAH/PSS-co-MA nanofilm architecture, as these films are more 
highly permeable.  With increased diffusion barriers, the effect of cooperativity could 
theoretically be lowered and sensor response characteristics made more stable. 
Regardless, glucose sensing MPACs were shown to be made with high 
sensitivity and analytical ranges within the physiologically-relevant glucose range.  The 
response attributes of these sensing MPACs can be modulated using nanofilm 
permeability, though these sensors are still dependent upon cooperativity.  As such, they 
could be susceptible to changes in effective pore concentration, which could change 
based upon swelling, for example.  Future optimization of MPAC glucose sensors will 
rely not only on the knowledge of diffusional effects of the LbL nanofilms utilized, but 
on a more in depth understanding of the pore cooperativity, which influences the glucose 
and oxygen distributions within the bulk.  This will require an analysis of average 
particle distances as well as diffusion/reaction behavior of glucose and oxygen in the 
bulk MPAC material within the gel utilizing both finite element modeling and in vitro 
study. 
This initial work has produced formulations of MPAC sensors that will function 
within the desired ranges of oxygen and glucose for in vivo measurement.  However, 
with the proper understanding of cooperative effects, glucose and oxygen sensing 
MPAC formulations could be better designed to account for, or utilize, these effects to 
produce optimized systems.  In addition, other sensing chemistries, either flux-dependent 
 132 
or independent, could similarly be incorporated into MPAC constructs for multianalyte 
and/or multimodal sensing applications.  
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6. CONCLUSIONS AND FUTURE WORK 
 
6.1 Conclusions 
This work demonstrates the fabrication, mechanical evaluation, and sensor 
response modulation of a novel injectable material, microporous alginate composite 
(MPAC).  By adjusting input parameters, this system can be utilized to control the 
gelation rate of bulk alginate materials as well as encapsulate sensing and therapeutic 
agents for the monitoring and treatment of chronic disease.  The properties of the 
composites were shown to be modulated by adjusting the porosity and numbers of 
polyelectrolyte bilayers used in their fabrication. 
To determine the feasibility of the novel system as a functional injectable system, 
several important criteria were evaluated including the loading of model 
macromolecules, nanoparticles and catalytic components, retention of these components, 
and interaction of the catalytic components with the external environment.  Utilizing the 
encapsulation properties of CaCO3, fluorescently labeled-bovine serum albumin, various 
sizes of FluoSpheres (20, 100, 200 nm), and glucose oxidase were loaded into 
microspheres.  Polyelectrolyte multilayers were deposited on the loaded-CaCO3 
microspheres to retain these molecules.  MPAC hydrogels were fabricated using these 
loaded particles and the internal gelation technique utilizing glucono-δ-lactone.  MPAC 
hydrogels fabricated in this fashion retained the functional elements within distinct pore 
structures, where encapsulated material could freely move and interact with externally-
supplied substrates.  The novel addition of polyelectrolyte multilayers to the internal 
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gelation of alginate matrix not only allowed for the retention of material, but also was 
observed to affect the gelation kinetics of the composite. 
To better understand how MPAC gelation kinetics could be modulated and how 
these changes affect the composite after gelation, a series of experiments was performed 
in which MPAC fabrication parameters including the concentration of CaCO3 particles 
and the numbers of polyelectrolyte bilayers utilized were varied.  Gelation times, pH 
evolution, and mechanical properties of the material were evaluated for dependence on 
fabrication parameters.  MPAC hydrogels were shown to have controllable gelation 
kinetics based upon particle concentration as well as numbers of bilayers, with larger 
numbers of layers and lower particle concentrations resulting in extended gelation times.  
pH changes within the composites were shown to remain within safe levels during 
gelation, and were similarly dependent on fabrication parameters.  Utilizing easily 
tunable particle concentrations and polyelectrolyte multilayer architectures, future 
MPAC-based devices could be tailored to gel at a rate and strength suited for their 
application site, whether located in the subcutaneous, joint capsule, or epidural space.  
The mechanical stability of the hydrogels in DI water using dynamic mechanical 
analysis (DMA) gave insight into the physical changes happening within the hydrogel 
matrix as a function of fabrication parameters.  Gels containing lower numbers of 
particles displayed the most swelling and the least stability of MPACs tested, while high 
concentrations of particles showed little or no change after solvent exposure.  The 
polyelectrolyte materials utilized had minimal impact on the swelling/stability behavior 
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of MPACs except within highly unstable regions of the fabrication parameters (such as 
around 1x concentration and 10-20BL). 
The DMA method, while utilized in the this work to determine general solvent 
stability of MPACs, is envisioned to be utilized further for assessing stability of MPAC 
gels under various destabilizing conditions such as in the presence of high 
concentrations of monovalent cations, as well as in the presence of protein and enzymes 
found in body fluid.  These experiments will be of utmost importance in evaluating 
appropriate degradation profiles for in vivo experiments, and for potentially developing 
designed degradation profiles of the composite based upon the fabrication parameters 
and utilization of additional degradation strategies such as partial oxidation of alginate.  
In addition, incorporating degradable polyelectrolytes, such as chitosan, alginate, 
poly(L-lysine), or dextran sulfate could allow for the development of fully-degradable 
hydrogels. 
In addition to showing modulation of gelation kinetics and material properties, it 
was shown that MPAC gels were able to function either as an oxygen or glucose-sensing 
material by incorporation of an oxygen-sensitive phosphor or the phosphor and glucose 
oxidase respectively.  These two specific examples of sensor chemistry embody two 
different transduction mechanisms that can be utilized in a diverse set of dye and 
enzyme molecules.  Thus, in principle, MPAC gels could be utilized to house other flux 
independent luminescent chemistries as well as flux/reaction dependent sensing 
chemistries relying on enzymes such as oxidoreductases.  Of the two sensing chemistries 
studied, both displayed high sensitivity when incorporated within MPAC hydrogels.  
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Oxygen-sensitive MPAC gels were shown to be highly sensitive in the physiologically-
relevant oxygen range (< 100µM), displaying great utility for tissue oxygen 
measurement.  Glucose-sensitive MPACs displayed variable sensitivities and ranges 
depending on the concentration of particles utilized as well as the numbers of 
polyelectrolyte bilayers.  Appropriate fabrication parameters were determined for high 
sensitivity within the physiologically relevant glucose range (40-400 mg/dL). 
Due to the dependence of glucose-sensing MPACs on particle concentration, it 
was hypothesized that pores within the MPACs were behaving in a cooperative manner.  
Cooperativity has been recognized as a likely characteristic of microparticle and 
microdomain systems, but it has not been studied in depth in our laboratory.  MPAC gels 
may offer a means to study this phenomenon.  As MPAC gels provide a means to 
immobilize precise concentrations of particles with known enzyme concentrations, 
models comparing relative reaction rates, diffusion parameters and particle spacing 
could be directly compared to in vitro results.  While highly academic in nature, the 
understanding of cooperative behaviors in silico and in vitro will enhance the 
development and testing of microparticle/microcapsule sensors, including flux-based 
MPAC sensors, and help future scientists design these sensors appropriately. 
It is important to appreciate that the MPAC composite system has the potential to 
not only perform as an injectable single sensor system, but as a multimodal or 
multifunctional system.  This is one area where MPAC hydrogels could make a 
significant impact in the advancement of implantable devices, providing multiple, 
tunable functionalities within a single construct.   Future work will be focused on the 
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development of multiple capabilities of the composite beyond oxygen and glucose 
sensing.  Some preliminary work has been completed to demonstrate the feasibility of 
MPAC-based multimodal sensors and controlled release systems.  The following 
sections detail two examples of these: SERS-based sensing and drug delivery. 
6.2 SERS-based sensing MPACs 
Towards additional sensing applications, recent preliminary work has focused on 
implementing surface enhanced Raman spectroscopy (SERS) to serve as another sensing 
modality in addition to phosphorescence lifetime and intensity.  The Raman-active dye 
4-aminothiophenol (4-ATP) is capable of producing a change in its Raman spectrum as a 
result of pH change in the solution.  This dye can be conjugated to gold nanoparticles to 
produce a SERS spectrum.  Preliminary data have suggested that 4-ATP-modified gold 
nanoparticles can be encapsulated within CaCO3, coated in polyelectrolytes, and made 
into an MPAC hydrogel, which can be examined using Raman spectroscopy (Appendix 
B.1, Figure 56).  However, these results are limited to very concentrated MPAC 
samples, which have not been optimized.  Strong SERS peaks for 4-ATP have been 
reported at 1587, 1078, and 391,210 which correspond closely to peaks observed for 
nanoparticle-loaded MPACs (Figure 56, arrows).  Additional work is required to confirm 
these results and optimization of the process will likely be required prior to testing of the 
pH sensing chemistry simultaneously with phosphorescence chemistry.  This pH sensing 
chemistry could also be put to use in combination with glucose oxidase, which produces 
acid as a result of its reaction with glucose and oxygen (6.1-6.2), to create another type 
of glucose-sensitive chemistry. 
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(6.1) Glucose + O2
GOx
→ Glucono-δ-lactone +H2O2 
(6.2) Glucono-δ-lactone + H2O 
k1([OH−])
↔      Gluconate− + H+ (hydrolysis) 
In a short span of time, oxygen, glucose and pH sensitive elements utilizing two 
different sensing modalities could be incorporated within an MPAC gel, creating a true 
multimodal sensor.  In addition, other sensing systems based upon oxidoreductases such 
as lactate oxidase could be utilized in combination with glucose oxidase to produce a 
variety of different multianalyte/multimodal sensors. 
 
 
Figure 56: RAMAN spectra of 4ATP-modified gold nanoparticles (blue), alginate 
(red), and MPAC hydrogel containing 4-ATP-modified gold nanoparticles (green).  
Arrows point to 4-ATP and MPAC peaks that correspond to each other and to 
referenced 4-ATP peaks. 
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6.3 Drug delivery with MPACs 
Another important application for MPAC gels is the storage and delivery of 
therapeutics for drug delivery applications.  Future work in this area will involve the 
encapsulation of model therapeutics and the tuning of release profiles for both passive 
and stimulated release.  Preliminary work (Appendix B.2) has shown some promising 
results in this direction.  CaCO3 microspheres have been shown to be capable of loading 
both rhodamine 101 (R101) and rhodamine B-labeled aminodextran (3k) (RBD) 
representing a model small molecule (R101) and peptide (RBD) respectively.  MPACs 
fabricated with these loaded particles have shown to release the materials (Figure 57). 
When utilizing highly permeable layer-by-layer consisting of PDADMAC/PSS 
only (Figure 57, top), release of RBD showed no diffusion inhibition due to 
polyelectrolytes.  In the case of less permeable layers (PDADMAC/PSS + PAH/PSS-co-
MA as in Section 5), release of R101 showed release only in 0-10 bilayers of 
polyelectrolyte (Figure 57, bottom) and retained loaded material above 10 bilayers (not 
shown).  This phenomenon may have more to do with the solubility of the dye rather 
than its transport through the nanofilms.  If dye were to precipitate after or during the 
dissolution of CaCO3, then the release of dye would be greatly inhibited due to a large 
proportion of the dye being in a larger form factor.  In the case of RBD, the molecule is 
extremely hydrophilic, and so that molecule is unlikely to precipitate.  While additional 
studies need to be performed to confirm these hypotheses, these data do indicate the 
potential of MPAC gels to encapsulate and release therapeutic materials.  However, a 
great deal of extra work will need to go into exploring the effects of coprecipitation on 
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specific dye/drug molecules as well as the optimization of nanofilms to create the 
appropriate diffusion barriers. 
 
 
 
Figure 57: Preliminary release kinetics of rhodamine B-labeled aminodextran (top) 
and rhodamine 101 (bottom) from alginate matrices with varying numbers of 
polyelectrolyte bilayers.  LbL used in aminodextran release was of PDADMAC/PSS 
architecture, while rhodamine 101 release utilized PDADMAC/PSS + PAH/PSS-co-
MA architecture. 
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The last and arguably the most important future direction of MPAC development 
is the in vivo evaluation of MPAC gels.  While it is likely that MPAC hydrogels will 
have favorable host response (alginate materials have generally been shown to be 
biocompatible), gelation kinetics, mechanical stability, and host reaction to the alginate 
matrix will need to be determined if MPAC hydrogels are going to be utilized in whole 
or as part of future biomedical devices.  The first set of in vivo experiments will need to 
focus on the determination of gelation properties in vivo, degradation of implants over 
time, as well as the host response to the implants. 
With many different potential applications, study of the MPAC material could 
branch out into many different areas; the previously discussed areas represent only a few 
of them.  The work presented here confirms the tunable nature of MPAC hydrogel 
functionality, which gives the material advantages as a platform for different 
multianalyte/multimodal sensing applications.  This work represents the beginning of 
this material’s development and demonstrates its potential as a tool to improve 
monitoring and treatment of chronic conditions. 
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APPENDIX A                                                                                              
AUTOMATED ANALYSIS FOR OXYGEN AND GLUCOSE SENSORS 
 
Automated code was utilized to quickly analyze large quantities of data produced 
by the custom time domain lifetime system for oxygen and glucose experiments.  The 
code, written in MatLab script, is shown below.  Each part of the code is explained in 
line with comments marked using the “%” symbol and is displayed in green. 
A.1 Two-site Stern Volmer fitting code for oxygen sensors 
 
%%%% 
%MPA O2 Sensor Analysis 
%%% 
clear all 
close all 
%%File Names 
BL=cellstr(['5 '; '10'; '15'; '20'; '25'; '30']); %file designations referring to the number of 
bilayers in sample 
air=cellstr(['GG  '; '10% '; '25% '; '50% '; '100%']); %file designations referring to the 
concentration of air bubbled in the reservoir 
samp=cellstr(['1'; '2'; '3']); %file designations referring to sample number 
filepath='filepath'; 
%%Oxygen values 
O2equil=  208.7; %Corrected O2 concentration (uM) at equilibrium (37C and 
1.3%salinity) 
O2=[0,.1, .25, .5, 1]*O2equil; %Corrected O2 concentration array 
%%Loading and averaging raw data 
for i=1:length(BL) 
    for j=1:length(air) 
        for k=1:length(samp) 
        loadfile = strcat(filepath, '\', char(BL(i,1)), 'BL3x', char(air(j,1)), '-s', 
char(samp(k,1)),'.xls'); %read data file 
        data = dlmread(loadfile); 
        for a=length(data):-1:length(data)-30 
            lt(length(data)-a+1,k)=data(a,4); %resize data matrix, cutting out extra cells 
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        end 
        ltavg(j,k)=mean(lt(:,k)); %calculate the mean lifetime at a single oxygen 
concentration within a sample 
        end 
  
        BLavg(i,j)=mean(ltavg(j,:)); %mean array containing each sample type and oxygen 
concentration 
        BLconf(i,j)=std(ltavg(j,:))*1.96/3^.5;%confidence interval for each mean 
   
  
    end 
  
%%Two-site SV fit: 
        ft = fittype( '((f/(1+Ksv1*x))+((1-f)/(1+Ksv2*x)))^-1', 'independent', 'x', 'dependent', 
'y' ); %fit equation defined 
        opts = fitoptions( ft ); 
        opts.StartPoint = [1 0.002 0.8]; %initial guesses for parameters 
        opts.Lower = [0 0 0]; %lower bounds for parameters 
        opts.Upper = [Inf Inf 1]; %upper bounds for parameters 
        fitresult= fit( O2', tinv(:,k), ft, opts ); 
        plot(fitresult) 
        Ksv1(i,k)=fitresult.Ksv1; %Ksv1 values in array 
        Ksv2(i,k)=fitresult.Ksv2; %Ksv2 values in array 
        f(i,k)=fitresult.f; %f value in array 
  
        end 
        SVavg(:,i)=mean(SV(i,:)); 
        SVconf(:,i)=std(SV(i,:))*1.96/3^0.5; 
    save(savefile); 
    tinvtot{1,i}=tinv; 
end 
%Calculate means and confidence intervals for two-site parameters 
Ksv1conf=(std(Ksv1')*1.96/3^0.5)'; 
Ksv2conf=(std(Ksv2')*1.96/3^0.5)'; 
fconf=(std(f')*1.96/3^0.5)'; 
Ksv1avg=mean(Ksv1,2); 
Ksv2avg=mean(Ksv2,2); 
favg=mean(f,2); 
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A.2 Figure of merit analysis code for glucose sensors 
A.2.1 Raw data input and response calculations 
%%%%% 
%Raw data input and response calculations 
%%%%% 
clear all 
close all 
clc 
file = 'filepath'; 
fn = 'filename' 
data = dlmread([file '\' fn '.xls']); %Load raw data from instrument output file 
for i=2:length(data) 
data(i,1)=data(i-1,1)+10; 
end 
lt = data(:,4)'; %Lifetime data 
i1 = data(:,5)'; %Intensity data 
c = data(:,3)'; %Concentration data 
time = data(:,1)'; %Time data 
time = time./3600; %Convert time to hours from seconds 
int_t = 0.1; %Use last 0.1 hours as steady state response 
samp_t = 15; %Seconds between samples 
num = int_t*3600/samp_t; %Determines number of measurements in steady state 
response time 
         
conc(1) = data(1,3); %First concentration 
for i=1:length(data(:,3)) 
    if(conc(length(conc))~=data(i,3)) 
        conc(length(conc)+1)=data(i,3); %Generates concentrations utilized 
    end 
end 
 c = data(:,3)'; 
j=1; 
for i=1:length(c)-1 
    if(c(i)~=c(i+1)) 
        index2(j) = i; %Determines at what point concentrations change 
        index1(j) = i-num; 
        j=j+1; %Logs place in array 
    end 
end 
index2(j) = i; 
index1(j) = i-num; 
[M, F] = mode(conc); 
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row = F-1; 
col = ceil(length(conc)/row); 
k=1; 
for i=1:row %For each concentration and number of runs, determine average lifetime 
and standard deviation for values in the steady state (determined by index1 and index2) 
    for j=1:col 
        values = lt(index1(k):index2(k)); 
        m(i, j) = mean(values); 
        n(i, j)=length(values); 
        st(i, j)=std(values); 
        e(i, j)=st(i)/sqrt(n(i)); 
        k = k+1; 
    end 
    k=k-1; 
end 
for i=1:row%Determine the percent change for each concentration at steady state 
    for j=1:col 
        p(i, j)=(m(i, j)-m(i, 7))/m(i, 1)*100; 
        pst(i, j) = ((st(i, j)+m(i, j))-m(i, 7))/m(i, 7)*100-p(i, j); 
    end 
end 
clear c 
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A.2.2 Concentration analysis 
%%%%%% 
%Glucose sensor analysis based upon concentration 
%%%%%% 
clear all 
close all 
clc 
  
  
%Find number of files 
set(0,'DefaultFigureWindowStyle','docked') 
r=0; 
nfile = 'filepath'; 
for k=1:10 
    fn=['MPA 30 BL ' num2str(k) 'x 1.mat']; 
    q=[nfile '\' fn]; 
    if(~exist(q)) 
        break; 
    end 
    r=r+1; 
end 
z=zeros(r,5); 
for s=1:r 
    for j=1:5 
    fn1 = ['MPA 30 BL ' num2str(s) 'x ' num2str(j) '.mat']; 
    q1= [nfile '\' fn1]; 
    if(~exist(q1)) 
        break; 
    end 
    z(s,j)=1; 
end 
end 
%%Load files 
for w=1:r 
for y=1:sum(z((w),:)) 
    fn =  ['MPA 30 BL ' num2str(w) 'x ' num2str(y) '.mat']; 
     q= [nfile '\' fn]; 
    load(q); 
    MPA(y,:) = m; %Lifetime values 
    MPAst(y,:)=st; %Standard deviation in lifetime 
    c1(y,:)=c; %Glucose concentrations 
    MPAp(y,:)=p; %Percent change 
    MPAstp(y,:)=pst; %Standard deviation in percent change 
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    %insert fit 
    [xData, yData] = prepareCurveData( c, m ); 
  
%%Set up sigmoidal fit and options. 
    ft = fittype( 'a/(1+b*exp(c*x))+d', 'independent', 'x', 'dependent', 'y' ); 
    opts = fitoptions( ft ); 
    opts.Display = 'Off'; 
    opts.Lower = [-1000 0 0 0]; 
    opts.StartPoint = [-300 0.6 0.02 300]; 
    opts.Upper = [0 10 5 1000]; 
  
%%Fit model to data 
    [fitresult, gof] = fit( xData, yData, ft, opts ); 
     
%%Response time calculations 
    lt = data(:,4);%Load lifetime 
    i1 = data(:,5)';%Load glucose concentrations 
    c = data(:,3)'; 
    time = data(:,1);%Load time data 
    time = time./3600;%Change time to hours 
    moveavgpt=20;%Determine number of points to average in moving average 
%%Smoothing spline for RAW 
    [xData, yData] = prepareCurveData(time, lt); 
  
    % Set up fittype and options. 
    ft = fittype( 'smoothingspline' );%Smooth curve for response time analysis 
    opts = fitoptions( ft ); 
    opts.SmoothingParam = 0.999999; 
  
    % Fit model to data. 
    [fitresult2, gof] = fit( xData, yData, ft, opts ); 
    y1= feval(fitresult2,time); 
%%Determine response time 
    for e=1:length(index2)-2%index2 represents where concentrations change in time 
    for v=1:length(y1) 
        if v+index2(1,e)+moveavgpt/2 > length(y1)%Breaks code if limit in length reached 
(no solution) 
            start=index2(1,e); 
        break 
        end 
        moveavg=sum(y1(v+index2(1,e)-
(moveavgpt/2):(v+index2(1,e)+(moveavgpt/2)),1))/moveavgpt; 
        if moveavg > 3*st(1,e)+y1(index2(1,e),1)%If value in lifetime exceed three times 
the standard deviation of the previous average lifetime, set as start of response 
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            start=v+index2(1,e); 
             
        break 
        end 
    end 
     for en=1:length(y1) 
        if en+index2(1,e)+moveavgpt/2 > length(y1)%Breaks code if limit in length 
reached (no solution) 
            ends=index2(1,e); 
            break 
        end 
        moveavg2=sum(y1(en+start-
(moveavgpt/2):(en+start+(moveavgpt/2)),1))/moveavgpt; 
        if moveavg2 > m(1,e+1)-3*st(1,e+1)%If lifetime approaches 3 times the standard 
deviation below the next average lifetime, call this the end point 
            ends=en+start; 
             
        break 
        end 
     end 
     tr(1,e)=time(ends,1)-time(start,1);%Response time is determined as the difference in 
time of the end and start points 
     resp(y,w)={tr}; 
    end 
     
     
%%FOM calcs 
    MPAmax(y,w)=fitresult.d; %Highest lifetime value (asymtote) 
    sigmabase3(y,w)=st(1,1)*3; %Standard deviation in baseline 
    sigmatop3(y,w)=st(1,6)*3; %Standard deviation at highest glucose concentration 
    baseline(y,w)=(m(1,1)+m(1,7))/2; %Averaged baseline lifetime values (before and 
after glucose) 
    LODy(y,w)=baseline(y,w)+sigmabase3(y,w); %Limit of detection y coordinate 
    LOD(y,w)=log(((fitresult.a/(LODy(y,w)-fitresult.d))-1)/fitresult.b)/fitresult.c; 
%Corresponding limit of detection 
    ARtopy(y,w)=fitresult.d-sigmatop3(y,w); %Top of the analytical range y coordinate 
    ARtop(y,w)=log(((fitresult.a/(ARtopy(y,w)-fitresult.d))-1)/fitresult.b)/fitresult.c; 
%corresponding top of analytical range 
    AR(y,w)=ARtop(y,w)-LOD(y,w); %Analytical range 
    sense(y,w)=((ARtopy(y,w)-LODy(y,w))/LODy(y,w)*100)/AR(y,w);%Sensitivity 
end 
  
  
%%Log data per sample 
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MPAm(w,:) = mean(MPA); %Mean lifetime values at each glucose concentration and 
sample type 
MPAstm(w,:)=std(MPA);%Standard deviation of mean lifetime values at each glucose 
concentration and sample type 
MPAconf(w,:)=std(MPA)*(1.96/(sum(z((w),:))).^.5);%95% confidence intervals of 
mean lifetime values at each glucose concentration and sample type 
  
MPAmp(w,:)=mean(MPAp);%Mean percent change values at each glucose 
concentration and sample type 
MPAstmp(w,:)=MPAstm(w,:)/MPAm(1,1)*100;%Standard deviation of percent change 
values at each glucose concentration and sample type 
MPAconfp(w,:)=MPAconf(w,:)/MPAm(w,1)*100;%95% confidence intervals of percent 
change values at each glucose concentration and sample type 
  
  
clear MPA MPAst MPAp MPAstp 
end 
%%initial response time calculations 
clear c1 
for i=1:5 
    c1(i,:)=resp{i,5}*60; %concentration 1x response times 
    c2(i,:)=resp{i,4}*60;  %concentration 2x response times 
    c3(i,:)=resp{i,3}*60; %concentration 3x response times 
    c4(i,:)=resp{i,2}*60; %concentration 4x response times 
    c5(i,:)=resp{i,1}*60; %concentration 5x response times 
end 
c1m=mean(c1,1); %Mean response times 
c2m=mean(c2,1); 
c3m=mean(c3,1); 
c4m=mean(c4,1); 
c5m=mean(c5,1); 
  
c1s=std(c1,1); %Standard deviation of response times 
c2s=std(c2,1); 
c3s=std(c3,1); 
c4s=std(c4,1); 
c5s=std(c5,1); 
  
c1conf=std(c1,1)*1.96/(5^0.5); %95% confidence intervals of response times 
c2conf=std(c2,1)*1.96/(5^0.5); 
c3conf=std(c3,1)*1.96/(5^0.5); 
c4conf=std(c4,1)*1.96/(5^0.5); 
c5conf=std(c5,1)*1.96/(5^0.5); 
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initresp(1,1)=c1m(1,1); %Mean initial response times 
initresp(1,2)=c2m(1,1); 
initresp(1,3)=c3m(1,1); 
initresp(1,4)=c4m(1,1); 
initresp(1,5)=c5m(1,1); 
  
initrespconf(1,1)=c1conf(1,1); %95% confidence intervals of initial response times 
initrespconf(1,2)=c2conf(1,1); 
initrespconf(1,3)=c3conf(1,1); 
initrespconf(1,4)=c4conf(1,1); 
initrespconf(1,5)=c5conf(1,1); 
  
%%Means and confidence intervals for figures of merit 
LODavg=mean(LOD,1); %Limit of detection means 
LODconf=std(LOD,1)*1.96/5^0.5;%Limit of detection 95% confidence intervals 
ARtopavg=mean(ARtop,1); 
ARtopconf=std(ARtop,1)*1.96/5^0.5; 
senseavg=mean(sense,1);%Mean sensitivities 
senseconf=std(sense,1)*1.96/5^0.5; 
ARavg=mean(AR); 
ARconf=std(AR)*1.96/5^0.5; 
 
A.2.3 Bilayer analysis 
%%%%%% 
%Glucose sensor analysis based upon bilayer numbers 
%%%%%% 
clear all 
close all 
clc 
  
  
%%Find files of data 
set(0,'DefaultFigureWindowStyle','docked') 
r=0; 
nfile = 'filepath'; 
z=zeros(r,6); 
aa=0; 
for s=1:6 % 
    h=35-s*5; 
    aa=aa+1; 
    for j=1:5 
    fn1 = ['MPA ' num2str(h) ' BL 3x ' num2str(j) '.mat']; 
    q1= [nfile '\' fn1]; 
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    if(~exist(q1)) 
        break; 
    end 
    z(aa,j)=1; 
end 
end 
b=0; 
%%Load files 
for w=1:size(z,1) 
    g=35-w*5; 
    b=b+1; 
for y=1:sum(z((b),:)) 
    fn =  ['MPA ' num2str(g) ' BL 3x ' num2str(y) '.mat']; 
     q= [nfile '\' fn]; 
    load(q); 
    MPA(y,:) = m;%Lifetime values 
    MPAst(y,:)=st;%Standard deviation in lifetime 
    c1(y,:)=c;%Glucose concentrations 
    MPAp(y,:)=p;%Percent change 
    MPAstp(y,:)=pst;;%Standard deviation in percent change 
%%Set up sigmoidal fit and options. 
    [xData, yData] = prepareCurveData( c, m ); 
    ft = fittype( 'a/(1+b*exp(c*x))+d', 'independent', 'x', 'dependent', 'y' ); 
    opts = fitoptions( ft ); 
    opts.Display = 'Off'; 
    opts.Lower = [-1000 0 0 0]; 
    opts.StartPoint = [-300 0.6 0.02 300]; 
    opts.Upper = [0 10 5 1000]; 
  
    % Fit model to data. 
    [fitresult, gof] = fit( xData, yData, ft, opts ); 
     
%%Response time calculations 
    lt = data(:,4);%Load lifetime data 
    c = data(:,3)';%Load glucose concentrations 
    time = data(:,1);%Load time data 
    time = time./3600;%Convert time to hours 
    moveavgpt=20; %Number of points in moving average 
    %Smoothing spline for raw data 
    [xData, yData] = prepareCurveData(time, lt); 
  
    % Set up fittype and options. 
    ft = fittype( 'smoothingspline' ); 
    opts = fitoptions( ft ); 
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    opts.SmoothingParam = 0.999999; 
  
    % Fit model to data. 
    [fitresult2, gof] = fit( xData, yData, ft, opts ); 
    y1= feval(fitresult2,time); 
    %%Determine start and end times for response changes 
    for e=1:length(index2)-2 
    for v=1:length(y1) 
        moveavg=sum(y1(v+index2(1,e)-
(moveavgpt/2):(v+index2(1,e)+(moveavgpt/2)),1))/moveavgpt; 
        if moveavg > 3*st(1,e)+y1(index2(1,e),1) %If lifetime exceed three times the 
standard deviation of the previous mean lifetime, set as start of response 
            start=v+index2(1,e); 
             
        break 
        end 
    end 
     for en=1:length(y1) 
        moveavg2=sum(y1(en+start-
(moveavgpt/2):(en+start+(moveavgpt/2)),1))/moveavgpt; 
        if moveavg2 > m(1,e+1)-3*st(1,e+1)%If lifetime exceeds the next mean lifetime 
value minus three times the standard deviation of that mean , set as end of response 
            ends=en+start; 
             
        break 
        end 
     end 
     tr(1,e)=time(ends,1)-time(start,1);%Response is the difference in time from the star 
tto the end of response 
     resp(y,w)={tr}; 
    end 
     
     
%%FOM calcs 
    MPAmax(y,w)=fitresult.d;%Highest lifetime value (asymptote) 
    sigmabase3(y,w)=st(1,1)*3;%Standard deviation in baseline 
    sigmatop3(y,w)=st(1,6)*3;%Standard deviation at highest glucose concentration 
    baseline(y,w)=(m(1,1)+m(1,7))/2;%Averaged baseline lifetime values (before and 
after glucose) 
    LODy(y,w)=baseline(y,w)+sigmabase3(y,w);%Limit of detection y coordinate 
    LOD(y,w)=log(((fitresult.a/(LODy(y,w)-fitresult.d))-
1)/fitresult.b)/fitresult.c;%Corresponding limit of detection 
    ARtopy(y,w)=fitresult.d-sigmatop3(y,w);%Top of the analytical range y coordinate 
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    ARtop(y,w)=log(((fitresult.a/(ARtopy(y,w)-fitresult.d))-
1)/fitresult.b)/fitresult.c;%Corresponding top of analytical range 
    AR(y,w)=ARtop(y,w)-LOD(y,w); %Analytical range 
    sense(y,w)=((ARtopy(y,w)-LODy(y,w))/LODy(y,w)*100)/AR(y,w);%Sensitivity 
    
end 
  
%%Log data per sample 
MPAm(b,:) = mean(MPA);%Mean lifetime values at each glucose concentration and 
sample type 
MPAstm(b,:)=std(MPA);%Standard deviation of mean lifetime values at each glucose 
concentration and sample type 
MPAconf(b,:)=std(MPA)*(1.96/(sum(z((b),:))).^.5);%95% confidence intervals of mean 
lifetime values at each glucose concentration and sample type 
  
MPAmp(b,:)=mean(MPAp);%Mean percent change values at each glucose 
concentration and sample type 
MPAstmp(b,:)=MPAstm(b,:)/MPAm(1,1)*100;%Standard deviation of percent change 
values at each glucose concentration and sample type 
MPAconfp(b,:)=MPAconf(b,:)/MPAm(b,1)*100;%95% confidence intervals of percent 
change values at each glucose concentration and sample type 
  
sampnum(b,1)=sum(z((b),:)); 
clear MPA MPAst MPAp MPAstp 
end 
for i=1:5 
    b5(i,:)=resp{i,6}*60; %5BL response times 
    b10(i,:)=resp{i,5}*60; %10BL response times 
    b15(i,:)=resp{i,3}*60; %15BL response times 
    b20(i,:)=resp{i,3}*60; %20BL response times 
    b25(i,:)=resp{i,2}*60; %25BL response times 
    b30(i,:)=resp{i,1}*60; %30BL response times 
end 
b5m=mean(b5,1); %Mean response times 
b10m=mean(b10,1); 
b15m=mean(b15,1); 
b20m=mean(b20,1); 
b25m=mean(b25,1); 
b30m=mean(b30,1); 
  
b5s=std(b5,1); %Standard deviation of response times 
b10s=std(b10,1); 
b15s=std(b15,1); 
b20s=std(b20,1); 
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b25s=std(b25,1); 
b30s=std(b30,1); 
  
b5conf=std(b5,1)*1.96/(5^0.5); %95% confidence intervals of response times 
b10conf=std(b10,1)*1.96/(5^0.5); 
b15conf=std(b15,1)*1.96/(5^0.5); 
b20conf=std(b20,1)*1.96/(5^0.5); 
b25conf=std(b25,1)*1.96/(5^0.5); 
b30conf=std(b25,1)*1.96/(5^0.5); 
  
initresp(1,1)=b5m(1,1); %Mean initial response times 
initresp(1,2)=b10m(1,1); 
initresp(1,3)=b15m(1,1); 
initresp(1,4)=b20m(1,1); 
initresp(1,5)=b25m(1,1); 
initresp(1,6)=b30m(1,1); 
  
initrespconf(1,1)=b5conf(1,1); %95% confidence intervals of initial response times 
initrespconf(1,2)=b10conf(1,1); 
initrespconf(1,3)=b15conf(1,1); 
initrespconf(1,4)=b20conf(1,1); 
initrespconf(1,5)=b25conf(1,1); 
initrespconf(1,6)=b30conf(1,1); 
  
%%Means and confidence intervals for figures of merit 
LODavg=mean(LOD,1); %Limit of detection means 
LODconf=std(LOD,1)*1.96/5^0.5;%Limit of detection 95% confidence intervals 
ARtopavg=mean(ARtop,1); 
ARtopconf=std(ARtop,1)*1.96/5^0.5; 
senseavg=mean(sense,1);%Mean sensitivities 
senseconf=std(sense,1)*1.96/5^0.5; 
ARavg=mean(AR); 
ARconf=std(AR)*1.96/5^0.5; 
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APPENDIX B                                                                                                     
METHODS UTILIZED IN PRELIMINARY WORK 
 
B.1 SERS-based sensing MPACs 
B.1.1 Materials 
Poly(sodium 4-styrenesulfonate) (PSS, average Mw = 70,000 Da), 
poly(diallyldimethylammonium chloride) (PDADMAC, typical Mw range =  100,000-
200,000Da) , poly(allylamine hydrochloride) (PAH, average Mw = 15,000 Da), 
poly(sodium 4-styrenesulfonate-co-maleic acid) (PSS-co-MA, 1:1 monomer ratio, 
average Mw = 20,000 Da), alginic acid sodium salt from brown algae (281 cps for a 2% 
aqueous solution at 25 °C), and 4-aminothiophenol (4-ATP),  were obtained from Sigma 
and used without further purification.  Citrate-stabilized gold nanoparticles (20nm) were 
obtained from Nanopartz. 
B.1.2 Methods 
B.1.2.1 ATP-modified gold 
A solution was made by dissolving solid 4-ATP in 200 proof ethanol to a 
concentration of 0.5 mg/mL.  This solution was added to stock gold NP solution at a 1:1 
volume ratio.  The particles/4-ATP solution was then allowed to react overnight.  After 
reaction, particles were sonicated for 1 hour and washed 3 times by centrifuge filtration 
using 30 kDa Nanosep (Pall) filters (5,000 g, 2 minutes) and subsequent addition of 
ethanol.  Particles were then centrifuged down a final time (5,000 g, 2 minutes) and 
resuspended in 5 mM NaHCO3 (pH 8.0). 
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B.1.2.2 Loading of gold nanoparticles into CaCO3 
An aliquot of 400 µL of 4-ATP gold NPs (~2 x 1012 particles/mL) was added to 6 
mL of 0.2 M Na2CO3 in a 20 mL beaker and stirred with a 25 mm triangular stir bar.  A 
6 mL solution of 0.2 M CaCl2was then added to the gold NP solution under stirring.  The 
mixture was stirred for 30 seconds.  Stirring was then ceased and particles were allowed 
to mature over 10 minutes.  Particles were then centrifuged (250 g, 1 minute) and 
resuspended in 5 mM NaHCO3 buffer at pH 8.0 prior to layer-by-layer deposition. 
For LbL coatings, the particle suspension in 1 mL of 5 mM NaHCO3 (pH 8.0) 
was centrifuged at 500 g for 30 seconds and resuspended in 1 mL 5 mM NaHCO3 (pH 
8.0) with 20 mg/mL PDADMAC and allowed to incubate for 30 seconds.  The particles 
were then centrifuged down at 500 g, supernatant removed, and washed once with 1 mL 
5 mM NaHCO3 (pH 8.0).  The washed particles were centrifuged down again and 
resuspended in 1 mL 5 mM NaHCO3 (pH 8.0) with 20 mg/mL PSS and allowed to 
incubate for 30 seconds.  This process was repeated until there were 5 bilayers of 
PDADMAC/PSS.  After these layers, PAH and PSS-co-MA were deposited.  A 1 mL 
solution of 20 mg/mL PAH in 5 mM NaHCO3 (pH 8.0) was added to the packed 
particles with 5 bilayers, mixed, and allowed to incubate 30 seconds.  Particles were then 
centrifuged at 500 g and resuspended in 5 mM NaHCO3 (pH 7.2).  Washed particles 
were then centrifuged and resuspended in 5 mM NaHCO3 (pH 7.2) with 20mg/mL PSS-
co-MA and allowed to incubate 30 seconds.  PSS-co-MA-coated particles were then 
centrifuged, washed, and resuspended in 5mM NaHCO3 (pH 8.0).  This alternating 
process was repeated until 10 total bilayers were deposited. 
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B.1.2.3 MPAC fabrication and testing 
To ensure high signal intensity in Raman spectroscopy, highly concentrated 
MPAC gels (~8x) were fabricated.  For each gel, 6.8 mg of 4-ATP-loaded CaCO3 
particles were centrifuged down and resuspended in 25 µL DI water.  To this solution, 
50 µL of 3% (w/v) alginate was added and mixed.  A 25 µL solution of GDL (533 
mg/mL) was then added to the alginate/CaCO3 solution and mixed well.  The resulting 
pregel solution was immediately deposited into 3 separate wells (20 µL each) in a 30 µL 
well plate.  After gelation, gels were washed 3 times with 10 mM MES buffer (pH 5.7) 
and examined using a Renishaw System 1000 Raman spectrometer coupled to a Leica 
DMLM microscope (Schaunberg, IL) for Raman spectral characteristics. 
B.2 Drug delivery with MPACs 
B.2.1 Materials 
Poly(sodium 4-styrenesulfonate) (PSS, average Mw = 70,000 Da), 
poly(diallyldimethylammonium chloride) (PDADMAC, typical Mw range =  100,000-
200,000Da) , poly(allylamine hydrochloride) (PAH, average Mw = 15,000 Da), 
poly(sodium 4-styrenesulfonate-co-maleic acid) (PSS-co-MA, 1:1 monomer ratio, 
average Mw = 20,000 Da), alginic acid sodium salt from brown algae (281 cps for a 2% 
aqueous solution at 25 °C), rhodamine 101, and rhodamine B isothiocyanate (RITC) 
were obtained from Sigma and used without further purification.  Aminodextran (Mw = 3 
kDa) was obtained from Life Technologies. 
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B.2.2 Methods 
B.2.2.1 Aminodextran labeling with rhodamine B 
To produce rhodamine B-labeled aminodextran (3 kDa) (RITC-dextran 3k), a 
simple isothiocyanate reaction was utilized.  Aminodextran 3 kDa (50 mg) was added to 
10 mL 0.1 M NaHCO3buffer at pH 9.0.  To this solution, 35.7 mg RITC was added and 
stirred at room temperature for 1 hour.  Isopropyl alcohol was added until the labeled 
aminodextran was precipitated.  The precipitate was centrifuged, resuspended in a small 
quantity of water, and precipitated with IPA 5 additional times to remove any excess 
rhodamine B.  The final precipitate was then resuspended in water and lyophilized after 
flash freezing in liquid nitrogen. 
B.2.2.2 Loading of material into CaCO3 
CaCO3 microspheres were prepared by precipitation.  Briefly, Na2CO3 (0.25 M, 
8mL) containing either 1 mg/mL rhodamine 101 or RITC-dextran 3k was stirred 
vigorously in a 25 mL beaker with a 10 mm triangular stirbar.  CaCl2 (0.25 M, 8 mL) 
was then added to the solution under stirring.  The solution was stirred for 30 seconds 
after mixing, and then agitation was removed and the colloid was allowed to rest for 10 
minutes thereafter for particle maturation.  Particles were then collected, centrifuged and 
washed in 5 mM Na2CO3 pH 8.0 prior to layer-by-layer deposition. 
For LbL coatings, the particle suspension in 1 mL of 5 mM NaHCO3 (pH 8.0) 
was centrifuged at 500 g for 30 seconds and resuspended in 1 mL 5 mM NaHCO3 (pH 
8.0) with 20 mg/mL PDADMAC and allowed to incubate for 30 seconds.  The particles 
were then centrifuged down at 500 g, supernatant removed, and washed once with 1 mL 
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5 mM NaHCO3 (pH 8.0).  The washed particles were centrifuged down again and 
resuspended in 1 mL 5 mM NaHCO3 (pH 8.0) with 20 mg/mL PSS and allowed to 
incubate for 30 seconds.  This process was repeated until desired number of bilayers was 
acheived (from 0 to 10 for RITC-dextran and 5 for rhodamine 101).  For rhodamine 101-
loaded particles, additional layers of PAH and PSS-co-MA layers were deposited.  In 
this case, a 1 mL solution of 20 mg/mL PAH in 5 mM NaHCO3 (pH 8.0) was added to 
the packed particles with 5 bilayers, mixed, and allowed to incubate 30 seconds.  
Particles were then centrifuged at 500 g and resuspended in 5 mM NaHCO3 (pH 7.2).  
Washed particles were then centrifuged and resuspended in 5 mM NaHCO3 (pH 7.2) 
with 20 mg/mL PSS-co-MA and allowed to incubate 30 seconds.  PSS-co-MA-coated 
particles were then centrifuged, washed, and resuspended in 5 mM NaHCO3 (pH 8.0).  
This alternating process was repeated until the desired number of bilayers was achieved 
B.2.2.3 MPAC fabrication and testing 
All gels for release testing were manufactured at 1x relative concentration.  Gel 
precursors were made by centrifuging the appropriate amount of CaCO3 particles (3.4 
mg), removing the storage buffer (5 mM NaHCO3, pH 8.0), and adding deionized water 
(200uL).  Alginate (400 µL of 3% (w/v) in DI water) was then added and mixed.  GDL 
solution (66 mg/mL, 200 µL) was then added and the solution was mixed vigorously.  
Aliquots (200 µL) of each gel type were placed in individual well of a 96 well plate and 
allowed to gel for 24 hours. 
After 24 hours of gelation time, 150 µL release buffer (10 mM HEPES, pH 7.4) 
was then deposited on the surface of the gel.  At intermittant time points, 100 µL of 
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release buffer was taken from the wells and deposited in empty wells.  After removal of 
sample release buffer, the remaining release buffer in the MPAC wells was removed and 
replaced with 150 µL fresh release buffer.  Emission intensity was then read from the 
sample release buffer using a Tecan model Infinite M200 Pro plate reader to determine 
quantity of released material. 
 
 
